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 ii 
Drosophila melanogaster E93 is an early ecdysone response gene that encodes a 
pipsqueak domain transcription factor.  E93 is induced by ecdysone at the end of larval 
development, and directs the death and elimination of several larval tissues during 
metamorphosis.  Although E93 has been considered a dedicated regulator of larval cell 
death, I have found that E93 is also widely expressed in imaginal tissues during 
metamorphosis, where it is required for the proper patterning of many adult 
structures.  Our working hypothesis is that E93 functions in imaginal tissues as a 
metamorphosis-specific cofactor that determines the pupa-specific action of numerous 
other transcription factors involved in imaginal patterning.  For my thesis work, I focused 
on a single E93-dependent patterning process, the induction of bracts by bristle cells in 
the pupal leg.  This induction is known to be mediated by EGFR signaling.  My studies 
position E93 downstream of the transcription factor Pointed in the EGFR pathway, and 
upstream of the bract target gene Distal-less, consistent with the view that E93 functions 
to control target gene specificity of EGFR signaling during metamorphosis.   I also 
present the results of experiments to dissect functional domains within the E93 protein 
and to determine whether alternate products of E93 execute the cell death and imaginal 
patterning functions of E93.  
Abstract 
 
Chapter II-V will present these works in detail and Chapter VI will discuss future 
directions of this interesting project. 
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Chapter I :  Introduction and background 
In this chapter, I first present background information on ecdysone signaling and 
imaginal patterning during metamorphosis.  I then introduce the main character of my 
research: E93, a gene that appears to lie at the intersection of these two processes.  I end 
with our hypothesis that E93 functions as a metamorphosis-specific cofactor for many 
transcription factors involved in imaginal patterning.  
 
Ecdysone signaling 
Ecdysone is a steroid hormone that triggers major developmental transitions in 
Drosophila and induces different gene responses in a stage specific and tissue specific 
manner (Fig. I-1).  Ecdysone is synthesized in the prothoracic gland, and released into the 
haemolymph.  The first ecdysone pulse occurs during embryogenesis, and may play some 
role in cuticle deposition and morphogenesis (Chavez et al. 2000).  Ecdysone pulses 
during the first and second instars occur in combination with a high level of juvenile 
hormone, and trigger the two larval molts (Dubrovsky et al. 2000; Zhou and Riddiford 
2001).  As the level of juvenile hormone goes down at the end of the 3rd instar, a sharp 
increase of ecdysone drives the larva into pupariation and initiates metamorphosis.  
During metamorphosis, most larval tissues are eliminated, whereas imaginal tissues 
(future adult tissues) survive and differentiate into appropriate adult structures (Robertson 
1936).  
Ecdysone and the ecdysone receptor 
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The ecdysone receptor is a heterodimer of the ecdysteroid receptor (EcR) and 
Ultraspiracle (Usp), the Drosophila homologue of the retinoid X receptor (Yao et al. 
1992; Thomas et al. 1993).  Both EcR and Usp are members of the nuclear receptor 
superfamily (Mangelsdorf et al. 1995).  EcR and Usp heterodimers bind ecdysone and the 
complex then interacts with ecdysone response elements (EcRE) in target genes (Cherbas 
et al. 1991; Yao et al. 1993).  The EcR/Usp/ecdysone complex activates transcription of 
some targets, but represses others (Tsai et al. 1999; Schubiger et al. 2005). The EcR has 
three isoforms in Drosophila: EcR-A, EcR-B1, and EcR-B2 (Talbot et al. 1993).  These 
isoforms are expressed with different spatial and temporal patterns, and induce different 
transcriptional activities (Talbot et al. 1993; Truman et al. 1994; Cherbas et al. 2003). 
Thus, a variety of cellular responses have already been generated at the top of the 
ecdysone signaling hierarchy. 
           
Figure I-1: The hormonal regulation of the life cycle of Drosophila melanogaster 
Blue line represents ecdysone. Green line represents juvenile hormone. X axis represents 
development time in hours. It starts from the embryo and re-zeros at pupariation. 
 
24 48 72 96  0 12 24 48 72 96 
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The next components of the ecdysone signaling hierarchy are ecdysone response genes.  
At the end of the third instar, the EcR/Usp/ecdysone complex induces a cascade of 
ecdysone response genes.  Many of these genes were identified as puffs in late larval 
polytene chromosomes (Ashburner et al. 1974; Ashburner and Richards 1976).  Among 
these puff genes, a half dozen are called Early Puff Genes, which include the Broad-
Complex (BR-C), E74, E75, E63-1, E23 and E93 (Fig. I-2, Ashburner et al. 1974; 
Ashburner and Richards 1976; Thummel 2002).  The protein products of these Early Puff 
Genes work as transcription factors to induce more than 100 Late Puff Genes and to 
repress their own expression. The Late Puff Genes are divided into early-late genes (e.g. 
DHR3, E78, and E62E) and late-late genes (e.g. 22C, 63E, 71E, 82F).  The early-late 
genes require ecdysone/receptor complex for expression, whereas the late-late genes are 
repressed in the presence of ecdysone/receptor complex and hence are not induced until 
after the ecdysone pulse ceases.  The protein products of the Late Puff Genes function as 
effectors to regulate specific responses in different tissues. The second pulse of ecdysone 
around 10hr AP induces the Early Puff Genes and Late Puff Genes again (Ashburner et al. 
1974; Ashburner and Richards 1976; Thummel 1996; Thummel 2002).  
Ecdysone response genes 
 
The best characterized ecdysone response genes are the early genes BR-C and E74, which 
have a widespread impact in both larval and imaginal tissues (Kiss et al. 1988; Fletcher et 
al. 1995). The BR-C is further divided into three complementation groups: br, rbp and 
2BC (Belyaeva et al. 1980; Kiss et al. 1988). Each complementation unit encodes specific 
protein isoforms and its mutant alleles cause specific defects.  For example, br mutants 
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fail in imaginal disc eversion, rbp mutants fail to undergo salivary gland histolysis, and 
2Bc mutants are defective in imaginal disc fusion (Kiss et al. 1988; Emery et al. 1994).  
 
Figure I-2: The Ashburner model for the gene regulation by ecdysone during the 
metamorphosis 
Ecdysone binds to its receptor to form an EcR/Usp/Ecdysone active Complex, which 
induces Early Puff Genes and inhibits Late Puff Genes.  The protein products of Early 
Puff genes induce Late-Puff genes and inhibit their own expression. The second pulse of 
ecdysone around 10hr AP induces Early Puff Genes and Late Puff Genes again. 
 
Imaginal patterning  
Most work on the role of ecdysone signaling during metamorphosis has focused on early 
events after pupariation, including the death of larval tissues (such as the larval midgut 
Imaginal patterning and larval remodeling during metamorphosis 
Early puff genes Late puff genes 
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and salivary gland), and the evagination of the imaginal discs.  These events are 
controlled by the ecdysone peaks that initiate pupariation and that drive the prepupal to 
pupal molt.  Relatively little attention has been devoted to the subsequent strong and very 
broad ecdysone peak that occurs during mid-pupal development.  Many different 
imaginal patterning events take place at this time, and some of these events have been 
shown to require ecdysone signaling.  However, the ecdysone response genes responsible 
for executing these effects have not been identified. The work presented in this thesis 
indicates that the early response gene E93 is an important regulator of many of these 
pupal patterning processes.  Here I review the imaginal patterning processes known to 
take place in mid-pupal development.  These processes are of two types: the development 
of structures derived from imaginal discs and histoblasts, and the generation of adult 
structures by the remodeling of pre-existing larval structures. 
 
A common misconception is that the patterning of imaginal discs is essentially complete 
by the end of larval life, and that the role of ecdysone is simply to induce the 
morphogenesis and final differentiation of adult structures.  In fact, cell fate decisions 
involved in the patterning of imaginal structures continue throughout most of pupal 
development.  For example, in eye development the patterning of 2˚ and 3˚ pigment cells 
and the programmed cell death of excess lattice cells occurs between 24-48hr After 
Pupariation (AP) (Freeman 1996; Brachmann and Cagan 2003).  In the antenna, 
chemosensory sensilla are patterned in the mid pupal period (Sen et al. 2003) and 
outgrowth of the aristal plume and apoptosis of central core cells begins at about 30hr AP 
Patterning of imaginal discs and histoblasts during metamorphosis. 
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and lasts for 18-20hr (He and Adler 2001).  Specification of the maxillary palps takes 
place entirely after pupariation (Lebreton et al. 2008).  In the wing, final patterning of the 
veins by decapentaplegic (dpp) takes place during the pupal stage (for review see deCelis 
2003).  In the leg, induction of bracts by bristle cells takes place between 8 and 28 hrs 
after pupariation (del Alamo et al. 2002; Held 2002).  Finally, the abdominal cuticle is 
patterned almost entirely after pupariation, as the imaginal cells that give rise to the 
abdomen (the abdominal histoblasts) do not proliferate and replace the larval epidermal 
cells until after this time (Kopp and Duncan 1997; Kopp and Duncan 2002; Lawrence et 
al. 2002).  
 
Several adult structures are produced by remodeling of larval structures during the pupal 
stage.  Such remodeling has been studied extensively in neuronal cells and in the heart.  
Neuronal remodeling occurs in both the central nervous system (CNS) and in the 
peripheral system.  In the CNS, the early-born γ neurons (these are born between the 
embryonic and mid 3rd larval stages, and project into the γ lobe) of the mushroom bodies 
lose their larval axonal projections at 0-18hr AP, and then elaborate new adult-specific 
axonal projections during the early pupal stage (24-36hr AP) (Lee et al. 1999). Also in 
the CNS, the embryo-born olfactory Projection Neurons (PNs) (these are born in the 
embryo, receive input from olfactory receptor neurons in the antennal lobe, and project 
into the MB calyx and lateral horn) function in both the larval and adult olfactory system. 
These neurons prune their dendrites and axon branches during the first few hours of 
metamorphosis and later reinervate the adult mushroom body and lateral horn (Marin et 
Remodeling of pre-existing larval structures during metamorphosis 
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al. 2005). The pruning process of both early-born (γ) neurons and embryo-born PNs 
requires cell-antonomous reception of ecdysone signaling through the heterodimeric 
EcR-B1/Usp ecdysone receptor (Lee et al. 2000; Marin et al. 2005).  Another example of 
neuronal remodeling in the CNS is the Thoracic ventral (Tv) neurons. The Tv neuron 
dendrites are pruned back in the early pupal stage (5-18hr AP), and then establish adult-
specific branches in later pupae (18-48hr AP) (Schubiger et al. 1998; Brown et al. 2006). 
The pruning of Tv neurons requires the EcR-B1 or EcR-B2 isoforms (Schubiger et al. 
1998).  The pruning of larval dendrites in Tv neurons seems to result from transcriptional 
activation by the EcR complex, but the outgrowth of adult dendrites is more complicated. 
The outgrowth could either be a result of EcR-dependent transcriptional activation or a 
transcriptional derepression (Schubiger et al. 1998; Brown et al. 2006). 
 
In the peripheral nervous system, some of the dendritic arborization (da) neurons are 
remodeled during metamorphosis and function in the adult nervous system.  For example, 
the larval dendritic arbor of the dorsal da sensory neuron E (ddaE) is pruned back in the 
early pupal stage (10-25hr AP), and then regrows to produce the adult arbor at 40-54hr 
AP (Williams and Truman 2005). The pruning of dendritic and axonal arbors requires the 
EcR-B and EcR-B2 isoforms, but not the EcR-A isoform of the ecdysone receptor 
(Schubiger et al. 1998; Lee et al. 2000).  
 
The heart is also remodeled during metamorphosis. The morphology of the heart has been 
well characterized: in the embryo and larva, the cardiac tube is derived primarily from 
thoracic segment T3 and abdominal segments A1-A7, with segments T3-A4 forming the 
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larval posterior aorta, and segments A5-A7 forming the larval heart.  Each segment is 
composed of two Seven Up (Svp) expressing anterior myocytes and four Tinman (Tin) 
expressing posterior myocytes (Monier et al. 2005).  During the remodeling process, 
segments T3-A4 differentiate as the adult heart, and segment A5 becomes the terminal 
chamber of the adult heart by transdifferentiation.  In this process, A5 loses contractile 
activity, gains specific innervation, and undergoes changes in cell shape and polarity. 
Segments A6-A7 are eliminated by apoptosis (Monier et al. 2005).  
 
Remodeling of the larval heart is accomplished at least in part by the ecdysone-dependent 
transcriptional reprogramming of the Hox genes Ultrabithorax (Ubx) and abdominal-A 
(abd-A) (Monier et al. 2005). Ubx and abd-A are expressed within the larval aorta and 
larval heart, respectively, and are known to specify the identities of these regions (Lo et 
al. 2002; Lovato et al. 2002; Ponzielli et al. 2002). During metamorphosis, ecdysone 
causes Ubx to change its expression pattern: Ubx becomes repressed in Tin-expressing 
myocytes and restricted in expression to Svp-expressing myocytes.  Ecdysone has a very 
different effect on abd-A: in A5, it causes Abd-A to transition from specifying larval 
heart to specifying terminal chamber.  This transition involves a shift in the target gene 
specificity of Abd-A (see below) (Monier et al. 2005). 
 
Several of the metamorphosis-specific patterning events described above are known to 
involve dramatic changes in the effects of key transcription factors or developmental 
Key transcription factors and signaling systems change their target gene specificity in the 
transition from larval development to metamorphosis 
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signaling systems.  A good example occurs during wing vein patterning.  During larval 
life and in the first 8 hr APF, dpp is expressed in wing discs in anterior compartment cells 
located along the compartment boundary.  At this time, the dpp morphogen shapes the 
wing by controlling spalt, optomotor-blind (omb), and other downstream targets (de Celis 
et al. 1996; Grimm and Pflugfelder 1996; Nellen et al. 1996).  The expression of dpp 
along the compartment boundary is activated by Hh, which is secreted by posterior 
compartment cells and diffuses across the compartment boundary.  Although hh 
continues to be expressed in the posterior compartment of the wing throughout pupal 
development, at about 14 hr APF dpp becomes insensitive to Hh signaling, and 
expression of dpp along the compartment boundary is lost.  At about this same time, dpp 
becomes competent to respond to EGFR signaling, which drives dpp expression in the 
wing-vein primordia, where it directs the final differentiation of the veins (reviewed in 
De Celis 1998; Martin-Blanco et al. 1999; De Celis 2003).  Strikingly, expression of 
rhomboid, which is required for secretion of the EGFR ligand Spitz, is expressed in 
preveins in third instar larval discs as well as in pupal wings.  Thus, although both Hh 
and EGFR signals are present in both larval and pupal stages, dpp responds only to Hh in 
the larva, and only to EGFR signaling in the pupa.  The factors that drive this transition in 
the competence of dpp have not been identified.  The targets of Dpp signaling must 
undergo a similar transition during metamorphosis, as Dpp controls genes involved in 
patterning the wing blade in the larva, and genes involved in elaborating veins in the pupa.  
 
Many other examples indicate that a distinct regulatory environment exists during 
metamorphosis.  In the larval heart, Abd-A activates Ih (which encodes a protein for 
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intracellular cyclic nucleotide activated cation channel activity) and Ndae1 (Na+-driven 
anion exchanger 1), whereas in the pupa during remodeling, Abd-A transitions to 
repressing Ih and Ndae1 in the same tissue (Perrin et al. 2004; Monier et al. 2005).  In 
abdominal development, omb is regulated by Wg in early pupal development, but then 
loses its competence to respond to Wg and acquires competence to be activated by Hh 
signaling (Kopp and Duncan 1997; Kopp and Duncan 2002; Lawrence et al. 2002). 
Maxillary palp development is initiated by expression of Wg in the ventral region of the 
antennal disc after pupariation (Lebreton et al. 2008).  However, when Wg expression is 
driven here in the larva, antennal development is induced (Lebreton et al. 2008).  In the 
eye, ectopic expression of EGFR signaling has very different effects after pupariation 
than before (Freeman 1997).  In the wing, ectopic EGFR signaling induces vein 
development early in metamorphosis, but represses it at later times (Martin-Blanco et al. 
1999).  Additional evidence that a distinct regulatory environment is present during 
metamorphosis is provided by the identification of many enhancers that are specific for 
the larval or pupal stages.  Examples include pupal-specific antennal enhancers from the 
spineless (Emmons et al. 2007) and distal antenna related genes (D. Duncan, 
unpublished). 
 
A new connection between ecdysone signaling and imaginal patterning during 
metamorphosis 
It seems very likely that the metamorphosis-specific patterning events described above 
and their associated transitions in target gene specificity are controlled by ecdysone 
signaling.  However, this has been demonstrated to be true only for neuronal remodeling 
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and remodeling of the heart.  For my thesis work, I have shown that the ecdysone 
response gene E93 is required for many imaginal patterning events during metamorphosis, 
a finding that establishes a new connection between ecdysone signaling and these events.  
Below, I review what is known about E93. 
 
E93 was identified as an early puff gene induced by ecdysone (Baehrecke and Thummel 
1995).  E93 shows tissue-specific regulation not seen for other early ecdysone response 
genes.  In the larval midgut, E93 is induced by both the larval-prepupal ecdysone pulse at 
0 hr APF and by the prepupal-pupal pulse at about 10 hr APF.  However, in salivary 
glands, E93 is induced only by the second of these pulses  (Baehrecke and Thummel 
1995). The explanation for this difference is that E93 expression requires bftz-F1, which 
is not expressed in the salivary gland until mid-prepupa (Lavorgna et al. 1993; Baehrecke 
and Thummel 1995; Broadus et al. 1999).  BR-C, E74 and E93 trigger salivary gland 
apoptosis by inducing at least two cell death genes, rpr and hid (Lee et al. 2000; 
Thummel 2001).  Northern blotting of RNA from whole pupae indicates that E93 is 
induced until about 48hr AP (Fig. I-3, Fig. V-1, Baehrecke and Thummel 1995).  
Basic knowledge about E93 
 
Ecdysone 
E93 
Pupariation 
-18    -12      -6       0        6       12      18     24      30      36      42      48     54      60   
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Figure I-3: The stage specificity of the expression of E93 
E93 is induced by the first and second ecdysone pulses (0hr AP, 10hr AP) in the midgut 
and fat body. It is induced by the second ecdysone pulse (10hr AP) in the salivary gland. 
Northern blot from the whole animal indicates its expression is sustained until about 48 
hr AP. The blue line represents ecdysone pulses; the red line represents the induction of 
E93 expression. 
 
In the central nervous system, E93 is activated at 12hr AP, but this activation seems to be 
independent of ecdysone in organ culture experiments; in imaginal discs, E93 is induced 
mildly at 12hr AP, and input of ecdysone to this induction is unknown; in the fat body 
and midgut, E93 responds to both ecdysone pulses at 0hr AP and 10hr AP (Fig. I-4, 
Baehrecke and Thummel 1995). 
 
Figure I-4: The tissue specificity of the expression of E93 
Northern blot of  E93 total RNA from salivary glands, CNS, imaginal disc, fat body and 
gut at 0hr and 12hr AP (Baehrecke and Thummel 1995). 
In their molecular characterization of E93, Baehrecke and Thummel pieced together 
several partial cDNAs from the locus to infer a transcript of 9.5 kb that covers some 37kb 
of genomic sequence (the red transcript in Fig. I-5, Baehrecke and Thummel 1995). 
The transcriptional products of E93 
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Consistent with this transcript size, a transcript of 9.5 kb is detected on Northern blots 
using a probe from the 3' UTR (Baehrecke and Thummel 1995).  The predicted ORF of 
this transcript is 1165 amino acids long (the red shaded region in Fig. I-5). Recently, an 
alternate E93 cDNA of 4.5kb was described on FlyBase (LP08695; designated here as 
LP0, the green transcript in Fig. I-6). The LP0 cDNA has 3 novel 5' exons and a 
shortened 3' exon, and its predicted ORF (the green shaded region in Fig. I-5) encodes a 
protein of 1188 amino acids in which the N-terminal 9 amino acids of the E93 ORF are 
replaced by an alternate sequence of 32 amino acids. In my own cDNA screening, 
another cDNA of 4.6kb (designated Clone 2) was identified (the yellow transcript in Fig. 
I-5). Clone 2 has novel 5' exons and a shortened 3' exon, but its predicted ORF (yellow 
shaded region) is the same as E93. Since the 5' end of Baehrecke's E93 transcript was 
never determined, it is possible that its 5' end is the same as Clone 2.   
 
 
Figure I-5: Molecular map of three alternate transcripts of E93 
The green transcript represents LP0. The red transcript represents E93. The yellow 
transcript represents Clone2. Shaded areas represent the predicted ORF. The black arrows 
indicate the breakpoint of the dominant Tp(3;3)Vno mutant and the stop codon positions 
17760k    17770K    17780K    17790K    17800K    17810K   17820K   178305K    17840K 
Tp(3;3)Vno 
 
 
E93Vnol(3)ry93 E93Vnoe47 E93Vnoe31 E93Vnoe18 E931 
 
 
 
E93 
Clone2 
LP0 
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of E93Vnoe31, E93Vnoe47, E93Vnoe18 and E931 mutants respectively. The black triangles are 
insertions of two Doc elements and a P-element in the E93Vnol(3)ry93 allele. 
 
E93 is likely a transcription factor, as it contains a pipsqueak (pipsq) domain, which is a 
DNA-binding domain (Fig. I-6, pink region, Lehmann et al. 1998; Siegmund and 
Lehmann 2002). A second cryptic pipsq domain, which contains amino acid substitutions 
within the conserved pipsq domain helix-turn-helix region, is located 385 amino acids 
upstream of the canonical pipsq domain (Siegmund and Lehmann 2002). Both domains 
have high homology with honey bee Mushroom body large-type Kenyon cell specific 
protein-1 (Mblk-1) in two regions, designated as RHF1 (region conserved between 
honeybee and fruit fly 1) and RHF2 (Takeuchi et al. 2001). RHF2 is also conserved in the 
mammalian proteins Mblk1-related protein-1(Mlr1) and Mlr2 (Kunieda et al. 2003). Mlr1 
is expressed in mouse testis, implying a potential role in spermatogenesis (Kunieda et al. 
2003). Mblk-1 is expressed in the honeybee mushroom body, where it may be involved in 
synaptic plasticity (Takeuchi et al. 2001).  
The protein homology of E93 
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Figure I-6: E93 homologues from other species  
Mm (Mus musculus); Hs (Homo sapiens); Am (Apis mellifera); Dm (Drosophila 
melanogaster). MM, RHF1 and RHF2 are conserved motifs across species. Red pipsq is 
the canonical pipsqueak domain in fruit fly (modified from Kunieda et al. 2003). 
Lee et al. (2000) have described three mutant alleles of E93.  These are all defective in 
the death of larval midgut and salivary gland cells during metamorphosis (Fig. 1-7 A’).  
The E931 allele is associated with a nonsense change at codon 995, near the C terminus 
of the coding sequence (Fig. I-5).  Sequence changes have not been identified for the 
other two alleles (E932 and E933), which are unaffected in their coding sequences.  E932 
and E933 mutants show reduced accumulation of 9.5 kb E93 transcripts, suggesting that 
these alleles affect regulatory sequences of the gene (Lee et al. 2000). Because of the 
nature of the E93 product and the phenotypes of these mutant alleles, E93 has been 
viewed in the literature as a dedicated regulator of programmed cell death (Lee et al. 
2000; Siegmund and Lehmann 2002).  
The phenotype of E93 alleles 
 
My thesis work grew out of the discovery of three new alleles of E93 that have little 
effect on larval cell death, but instead cause numerous defects in pattern formation during 
pipsq 
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the pupal stage. These alleles were isolated by Eric Baehrecke in a screen for EMS-
induced lethals that fail to complement a deficiency that includes the E93 gene. This was 
the same screen that led to the recovery of the E931, E932, and E933 alleles.  When 
Baehrecke sorted the lethals he recovered into complementation groups, the three new 
alleles affecting imaginal patterning were placed into a separate complementation group, 
as they fully complement the E931, E932, and E933 alleles.  Baehrecke went on to show 
that the three mutations fail to complement the dominant wing-vein mutation 
Tp(3;3)Vein-off (Tp(3;3)Vno), and so he designated them as Vno alleles (Vnoe18, Vnoe31, 
and Vnoe47).  An additional allele [Vnol(3)ry93] was identified in the Bloomington P-
element insertion collection.  Because our laboratory was interested in the effects of the 
Tp(3;3)Vno mutation on the development of the abdomen, Dr. Baehrecke sent his Vno 
alleles to us for analysis.  Our lab mapped the P-element insertion in Vnol(3)ry93 to be 
1.5kb upstream of the 5' end of the E93 transcripts (see Fig. I-5) and then identified the 
Vnoe47, Vnoe31 and Vnoe18 mutants as nonsense mutations in codons 360, 545, and 783, 
respectively of the 1165 codon E93 sequence (Fig. I-5).  We also showed that Tp(3;3)Vno 
has a breakpoint located 36-37kb upstream of E93 (Fig. 1-5).  In light of these findings, 
the Vno mutations were renamed E93Vnoe18, E93Vnoe31, E93Vnoe47, and E93Vnol(3)ry93. 
 
E93Vno alleles fully complement the E931, E932, and E933 alleles, and hemizygotes show 
almost normal midgut and salivary gland cell death after pupariation.  However, E93Vno 
mutants do show numerous defects in imaginal patterning. Wing veins are completely 
absent, the abdominal tergites are only partially formed, most chemosensory sensilla are 
absent in the antenna and palp, the arista fails to branch, 2˚  and 3˚ pigment cells fail to be 
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specified properly in the eye, and bracts fail to form in the leg (Fig I-7).  Strikingly, all of 
these defects are in structures that are patterned during metamorphosis.  Our lab has 
failed to find any defects in E93Vno mutants prior to pupariation; even hemizygous mutant 
larvae from homozygous mutant germ line mothers develop normally until this time.  
This stage-specificity suggests that E93 encodes a metamorphosis-specific cofactor 
required in many imaginal patterning processes. My working hypothesis is that E93 
directs many of the pupal-specific target gene transitions described above.  My studies 
help establish a connection between ecdysone signaling and imaginal patterning during 
metamorphosis and are likely to provide important new insights into the temporal control 
of target gene specificity for key signaling systems used in development.  Why the E93Vno 
alleles complement the E931, E932, and E933 alleles has been difficult to understand, and 
is addressed in Chapter IV of my thesis. 
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Figure I-7: The phenotype of E931 alleles and E93Vno alleles 
A: Wild-type (E931/+) pupa at 24hr AP; salivary glands have been eliminated by this 
time (asterisk); but other tissues formed normally: adult eyes (e), brain (b), and adult 
wings (w). A’: E931/Df pupa at 24hr AP; redline circle the persistent salivary glands (sg) 
(Lee et al. 2000). B-F are wild type; B’-F’ are E93Vno mutants. B and B’ are legs (bracts 
are marked by arrows). C and C’ are wings. D and D’ are abdomen. E and E’ are antenna. 
F and F’ are eyes. The red lines outline the shape of cone cells in ommatidia. 
 
Summary of my work 
Through my four and half years work in Dr. Ian Duncan’s lab, I have made progress in 
the following areas (detailed information presented in Chapter II-V separately).  
1) Determination of the protein expression profile of E93. 
2) Determination of the position of E93 in the signaling pathway leading to the 
formation of bracts. 
3) Dissection of E93 protein domains required for its cell death and patterning 
functions. 
4) Identification of E93 transcripts responsible for the cell death and patterning 
functions of E93. 
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Chapter II : Determination of the protein expression profile of E93 
 
Abstract 
I designed antigens from three regions of the E93 coding sequence, produced these 
proteins in E. coli, and used them to immunize rabbits and mice either as single or mixed 
E93 antigens.  The E93 antisera obtained allowed the immunostaining of E93 in pupal 
tissues.  E93 is detected in the antenna, arista, eye, labellum, wing and leg in the pupal 
period, consistent with the multiple imaginal defects seen in E93Vno mutants.  The 
E93Vnoe47 mutant shows dramatically reduced staining, demonstrating specificity of the 
antisera. 
 
Rationale 
Although expression of E93 has been characterized early in metamorphosis in the larval 
midgut and salivary gland (Lee et al. 2000), later expression in imaginal tissues has not 
been examined.  An E93 antiserum (against codon 279-837) was generated by Dr. Eric 
Baehrecke (Lee et al. 2000).  However, this antiserum did not work well for Western 
blotting or tissue staining (personal communication), and is no longer available.  In order 
to gain a more complete picture of the expression of E93 during metamorphosis, it 
became necessary to generate a new E93 antiserum. 
 
Methods  
DNASTAR Lasergene 7 software was used to predict three regions with high antigenicity 
(Antigen I, II, and III, which include codons 47-126, 285-400, 999-1125 respectively (Fig. 
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IV-1); detailed sequence information can be found in the Appendix). These three regions 
were amplified and cloned into the pET28a vector by EcoRI and HindIII double digestion. 
Expression was induced in BL21 (DE3) cells, and proteins purified by His-Bind nickel 
chromatography, followed by dialysis in PBS overnight.  Preimmune serum was 
collected from animals prior to immunization, and stored in 50% glycerol at -70˚C. 
Mixtures of the 3 antigens were injected into 2 rabbits (Rabbit A and Rabbit B) and 3 
mice (Mice 1-3). Individual antigens (antigens I-III) were injected into 3 mice separately 
(Mice 4-6).  Rabbits were immunized 6 times with 110ug of protein at 1 month intervals. 
Mice were immunized 6 times with 10ug of protein at 1 month intervals. All 
immunization and bleeding procedures followed standard protocols. Sera were stored in 
50% glycerol at -70˚C. Rabbit B generated strong immune response in the 1st bleeding, 
and then the strength of the immune response went down (tested bleedings include 
preimmune, 1st, 2nd, 3rd and 6th bleeding). Rabbit A didn’t generate good immune 
response in the 1st bleeding, and the strength of the immune response didn’t get better 
until the 6th bleeding (tested bleedings include preimmune, 1st, 2nd, 3rd, and 6th). And even 
the strongest response from Rabbit A (6th bleeding Rabbit A) is weaker that the weakest 
bleeding from Rabbit B (1st bleeding from Rabbit B).  All mice sera, except Mouse 4, 
generated good immune response, and the strength of the immune response got better and 
better in each bleeding (tested bleedings include Mouse 1 preimmune, 1st, 2nd, Mouse 2 
preimmune, 2nd, Mice 3-6 preimmune, 1st, 2nd, 3rd). More details of the bleeding tests are 
available in the Appendix. The specificity and authenticity of tests of E93 antisera are 
shown in the Result section. 
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Antibody staining was by standard methods. Embryos were dechorionated in 50% freshly 
diluted Chlorox for 3 minutes, and fixed in 8ml PMG buffer (0.1M PIPES, 2 mM EGTA, 
1 mM MgSO4, pH 6.9), 10ml heptane, and 2ml 37% formaldehyde for 20 minutes, and 
devitellinized in 100% MeOH. Larvae and pupae were staged and fixed in 4% 
paraformaldehyde.  For 1˚ antibodies, chicken anti β -gal was used at a dilution of 1:200 
and all others (rabbit anti E93, mouse anti E93, mouse anti Distal-less (Dll), rabbit anti 
Pointed.P1) were used at 1:400. 2˚  antibodies (anti chick, anti rabbit, or anti mouse) were 
all used at 1:200.  
 
 
Images were taken using a Leica TCS SP 2 confocal system, or a Zeiss Photomicroscope 
III.  
 
Results 
Previous experiments indicated that E93 protein is expressed in midgut cells beginning at 
around 2hr AP and disappearing by about 13hr AP, whereas in the salivary gland, E93 
protein is not detected until around 10 hrs AP (Lee et al. 2000). With one exception, all 
rabbit and mouse antisera against E93 gave the expected result for staining of the midgut: 
positive nuclear staining was seen at 2hr AP (Fig. II-1 A), whereas staining was lost by 
13hr AP (data not shown). The antiserum from mouse 4, which was immunized with 
antigen I alone, did not show positive staining in midgut.  Staining of salivary glands was 
not as expected: antiserum from mouse 1 showed weak staining of salivary nuclei in both 
The specificity and authenticity of E93 antisera 
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13hr (Fig. IV-5 E) and 2hr AP pupae, but not in larvae. Mouse 2 showed weak staining of 
salivary nuclei in 2hr AP pupae, but not in larvae.  Mice 3, 5 and 6 showed weak staining 
of salivary nuclei in both 2hr AP pupae and larvae. Rabbits A and B showed weak 
staining of salivary nuclei in larvae, but not in 2hr pupae. The reason for these 
complicated staining results for salivary glands has not been explored further.  
 
Two lines of evidence demonstrate the specificity of the mouse and rabbit antisera 
generated.  First, E93Vnoe47 hemizygotes show a dramatic reduction in staining in both 
imaginal (bract - see below) and midgut cells (Fig. II-1 C, D).  Second, both mouse and 
rabbit antisera detect full length E93 protein expressed in en-Gal4; UAS-E93 embryos 
(Fig. II-1 B).  The rabbit antisera also show some staining in the anterior gut of the 
embryo.  This staining is likely due to cross reaction, as it is not reduced in the E93Vnoe47 
mutant, and is not seen with the mouse antisera.  Antisera from mice injected with single 
antigens show the expected staining specificity when used to stain embryos in which en-
Gal4 is used to drive expression of fragments of E93 (UAS-E931Nterm and UAS-
E93Vnoe47Cterm, see their molecular map in Fig. IV-1) (Fig. II-1 E-L).  Rabbit antisera 
were used for most of my experiments, as they are abundant.  Mouse antibodies were 
used only when required for double or triple antibody staining. 
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Figure II-1: E93 antigen authenticity tests 
A: Wild-type 2hr midgut stained by E93 antiserum from Mouse 3; B:  Embryo carrying 
en-Gal4>UAS-ORF-D1 stained by E93 antiserum from Rabbit B; C: Wild-type pupal leg 
at about 35hr AP stained by E93 antiserum from Rabbit B; D: E93Vno mutant pupal leg 
stained by E93 antiserum from Rabbit B; E-H are embryos carrying en-Gal4>UAS-
E931Nterm and UAS-GFP; I-L are embryos carrying en-Gal4>UAS-E93Vnoe47Cterm and 
UAS-GFP;  E, G, I and K are GFP positive controls to show that en-Gal4 drives UAS 
constructs in the expected pattern; F and J are stained by E93 antiserum II (Mouse 5);  H 
and L are stained by E93 antiserum III (Mouse 6); F and L suggest antisera from Mouse 5 
and Mouse 6 are specific to antigens II and III, respectively 
 
The expression profile of E93 in WT 
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When I stained wild-type pupae between 20-60hr AP, I detected E93 in multiple tissues. 
In general, E93 is expressed strongly between 30-35hrAP, and then gradually declines. 
At 30-35hr AP, E93 is expressed in every cell of antennal segments II and III (Fig. II-2 
A), throughout the wing (Fig. II-2 B, E), and in future pseudotracheal cells 
(pseudotracheae are hollow tubes on the surface of the labellum used for feeding) in the 
labellum (Fig. II-2 D).  In the eye, E93 is expressed in a complex pattern in each 
ommatidium (Fig. II-2 C, F), and in the leg, E93 is expressed in single cells located just 
proximally to each bristle (Fig. II-2 G, H).  In chapter III, these cells are identified as 
producing the leg bracts.  The expression of E93 detected by immunostaining 
corresponds well to the structures that are affected in the E93Vno mutants. As described 
above, E93 is also expressed in the nuclei of midgut caeca at 2hr AP (Fig. II-1 A), but 
disappears quickly and is not detected at 13hr AP (data not shown). E93 expression in the 
salivary gland is weak and variably detected by the different antisera. 
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Figure II-2: The expression profile of E93 in multiple tissues during metamorphosis 
Wild-type tissues at 30-35hr AP stained by E93 antiserum from Rabbit B. A: Antenna 
and arista; B: Wing; C: Ommatidia (top scanning); D: Labellum; E: Wing (enlarged 
scanning of B); F: Ommatidia (bottom scanning); G: Leg (top scanning); H: Leg (bottom 
scanning). 
 
Both the E93Vno alleles (including E93Vnoe47, E93Vnoe31, and E93Vnoe18) and the alleles 
affecting larval cell death (E931, E932, and E933) cause a strong reduction in E93 staining 
in 1-5hr AP midgut cells in hemizygotes (see Figure IV-3).  Hemizygotes for the E93Vno 
alleles also show strongly reduced E93 staining in prebract cells in 30-50 hr AP legs (Fig 
IV-3).  Hemizygotes for E931, E932, or E933 die early in pupal development, precluding 
examination of expression in bract cells in these mutants. 
E93 expression in E93 mutant hemizygotes 
 
Discussion 
The detection of E93 in the antenna, arista, ommatidia, wing and leg is consistent with 
the observation that E93Vno mutants cause patterning defects in these tissues.  The finding 
of E93 expression in the pseudotracheal cells of the labellum was a surprise, and suggests 
the involvement of E93 in the development of these structures although we haven’t 
checked whether E93Vno mutants affect their development.  Based on our hypothesis that 
E93 functions as a metamorphosis-specific cofactor, our expectation was that E93 would 
prove to be expressed very broadly in imaginal tissues in the pupal stage.  This 
expectation was borne out in the wing and antenna, where E93 is expressed in all or 
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almost all cells.  However, in the eye and leg, E93 shows highly restricted expression 
patterns.  The identities of E93-expressing cells in the eye have not been determined, but 
in the leg, expressing cells have been identified as future bract cells (see Chapter III). As 
described above, bracts fail to develop in the E93Vno mutants.  The picture that emerges 
for E93 is similar to that seen for the Hox genes.  Initial descriptions of the expression 
patterns for Hox genes were a great surprise, as genetic studies had suggested these genes 
would prove to be expressed uniformly within each developmental compartment.  Such 
uniformity was often found, but in some cases expression was limited to only specific 
structures within compartments.  One example from the recent literature is the finding 
that the Hox gene Scr, which controls first thoracic segment identity, is strongly 
upregulated in the sex comb region of the male first leg (Randsholt and Santamaria 2008). 
A likely possibility is that in the ancestral state Scr was expressed uniformly in the male 
T1 leg, where it came to specify sex comb development in the male among other T1-
specific structures.  Selection for increased development of the sex comb then led to 
selection for increased expression of its positive regulators, including Scr.  In response, 
Scr became incorporated into the patterning system that positions the sex comb, leading 
to high level expression within this specific structure.  If our working hypothesis (that 
E93 functions as a metamorphosis-specific cofactor) is correct, a similar series of events 
could have occurred in the evolution of high level E93 expression in bract cells.  
 
The E931, E932, and E933 mutants all cause strong reductions in E93 staining in the 2 hr 
AP midgut, consistent with the failure in larval cell death seen in these mutants.  The 
E93Vno mutants also cause a strong reduction of E93 staining in midgut cells, as well as in 
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the pre-bract cells of the pupal leg.  Why, then, do the E93Vno alleles almost fully 
complement the E931, E932, and E933 alleles?  One possibility is that the cell death 
function of E93 is executed by an alternate product of the locus, a possibility that is 
explored further in Chapter V.  The problem of the complementation of the E93Vno alleles 
and the alleles affecting larval cell death is addressed more fully in Chapter IV.  
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Chapter III : Determination of the position of E93 in the signaling pathway leading 
to the formation of bracts 
 
Abstract 
In order to understand the role of E93 in imaginal patterning, I focused on a single E93-
dependent process, the induction of bracts in the legs.  Bracts are small pigmented 
outgrowths that lie just proximal to most bristles in the legs.  They are patterned in the 
mid pupal stage by a relatively simple process: bristle or bristle-associated cells secrete 
the EGFR ligand Spitz, which induces bract formation in an adjacent epidermal cell (del 
Alamo et al. 2002; Held 2002).  In mosaic studies, I demonstrated that E93 is required in 
the epidermal (signal receiving) cell for bract formation.  I showed that argos, a common 
target of EGFR signaling, is induced in the pre-bract cell in normal development.  This 
induction is unaffected in E93Vno mutants, indicating that E93 lies downstream of the 
EGFR signaling pathway in bract development.  We were surprised to find that E93 is 
expressed in a very restricted pattern in the pupal leg: expression is restricted to single 
cells lying just proximal to each bristle.  Double labeling experiments show that these 
E93-expressing cells coincide with Distal-less (Dll) expressing cells, which are fated to 
produce bracts.  I show that expression of Dll in these cells requires E93+, and that 
expression of E93 in turn requires Pointed (Pnt), a transcription factor that lies at the end 
of the EGFR signal transduction pathway.  Ectopic expression experiments show that 
E93 is permissive for bract formation, whereas Pnt is instructive.  These findings suggest 
that E93 and Pnt work in concert to specify bract development, with E93 providing 
temporal information and Pnt providing spatial information.  Still unresolved is the role 
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of ecdysone signaling in the bract pathway: clones expressing an RNAi construct directed 
against a common region of the ecdysone receptor show some loss of bracts, indicating a 
requirement for ecdysone signaling.  However, it is not yet clear whether ecdysone is 
required for E93 expression in bract cells. 
 
Rationale 
The major goal of my dissertation is to determine the role of E93 in patterning during 
metamorphosis.  Why should E93 be required for patterning in the pupa, but not at other 
times?  Our hypothesis is that E93 is a metamorphosis-specific cofactor that confers 
pupal specificity to the targets controlled by a number of transcription factors.  Such a 
role would help account for numerous cases in which signaling pathways or transcription 
factors exert metamorphosis-specific effects (see Introduction).  
 
To understand the role of E93, we focused on a single E93-dependent process.  We 
decided to focus on bract formation in the leg because of its simplicity and the 
availability of a potential downstream target gene Dll.  Bracts are pigmented outgrowths 
of unknown function that are located just proximal to each mechanosensory bristle (Fig. 
I-3 B arrows).  They are completely absent in the E93Vno mutants (Fig. I-3 B’).  Previous 
studies have shown that bristle cells, or cells associated with bristle cells, secrete the 
EGFR ligand Spitz, which induces a neighboring epidermal cell to become a bract 
through the EGFR signaling pathway (del Alamo et al. 2002).  One potential target of 
EGFR signaling in these cells is the homeobox gene Dll, which is expressed in pre-bract 
cells beginning in mid pupal development, and is required for bract formation (Campbell 
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and Tomlinson 1998; Emmons et al. 2007).  Since the EGFR signaling pathway activates 
numerous downstream targets in different contexts, we hypothesized that E93 might 
serve as a metamorphosis-specific cofactor that controls the specificity of EGFR 
signaling in the pupal leg, targeting the Dll gene for activation (Fig. III-1). 
 
 
Figure III-1: Genes in the EGFR signaling pathway that may play potential roles in 
bract formation. 
The green arrow represents the EGFR ligand sent out from the bristle cell. Dotted lines 
indicate that other genes are omitted from the pathway.  
 
Methods 
E93Vno clones were generated by crossing y w FLP122; FRT82B CD2 y+ M(3)W Bsb / 
TM6B  ♀ to FRT82B sr es E93Vnoe47 ca/TM6B ♂, and then heat shocking larvae at 37˚C 
for 30 minutes.  Adult legs were mounted in a mixture of 38% Shandon Immu-Mount, 
53% filtered saturated chloral hydrate, and 10% filtered lactic acid, and placed on a slide 
warmer for 2 days at 45˚C.  E93Vno clones were identified by scoring the yellow marker in 
the cuticle of non-Tubby ♂ flies using a Zeiss Photomicroscope III. 
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For cuticular analysis, pnt- clones were generated by crossing y w FLP122; FRT82B CD2 
y+ M(3)W Bsb / TM6B  ♀  to FRT82 roe pp cu sr pntΔ88/TM6B ♂.  Heat shock and 
preparation of legs was as described above.  pntΔ88 is a null deletion allele of pnt (Scholz 
et al. 1993).  For analysis by confocal microscopy, pnt- clones were generated by crossing 
y w FLP122; FRT82 Ubi-GFP83/TM6B  ♀ with FRT82 roe pp cu sr pntΔ88/TM6B ♂, 
followed by heat shocking larvae at 37˚C for 30 minutes.  pnt- clones were identified as 
GFP minus clones in non-Tubby pupae.  
 
EcR-RNAi knock down clones were generated by crossing y w FLP12; Act>y+>Gal4 
UAS-GFP ♀ with UAS-EcR-RNAi ♂. EcR-RNAi knock down clones were identified by 
confocal microscopy as GFP positive clones in pupae, or as yellow clones in the cuticle of 
♂ flies using a Zeiss Photomicroscope III. 
 
E93 ectopic expression clones were generated in E93Vnoe47 mutant animals by crossing y 
w FLP12; Act>y+>Gal4 UAS-GFP; tub-Gal80ts E93Df/TM6B ♀ with UAS-E93-ORF; 
E93Vnoe47/TM6B ♂.  Progeny were raised at 25˚C until young larvae, and were heat 
shocked at 37˚ C for 7 min. Larvae were then moved to 19˚C until the early pupal stage, 
when they were shifted to 30˚C. Legs from non -Tubby pharate pupae were mounted as 
described above.  E93 ectopic expression clones were identified by scoring the yellow 
marker in the cuticle of non-Tubby ♂ flies using a Zeiss Photomicroscope III. 
 
Antibody staining and imaging were as described in Chapter II. 
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Results 
To determine whether E93 is required in the bristle (signal sending) cell or the bract 
(signal receiving) cell in the bract pathway, I generated mosaics for the E93Vnoe47 allele.  
In these mosaics, cells homozygous for E93Vnoe47 are marked by yellow cuticle.  The four 
possible genotypic combinations for bristle and bract cells are shown in Fig. III-2 A.  If 
E93 is required in the bristle cell, then only wild-type bristles (black bristles) can send out 
the right signal to the neighboring cells and induce bracts, but the bracts themselves could 
be either mutant (yellow) or wild type (black) (Fig. III-2 C).  Conversely, if E93 is 
required in bract cells, then only wild-type bracts (black bracts) will be induced, but 
bristles could be either mutant (yellow) or wild type (black) (Fig. III-2 D).  The second 
result was obtained, indicating that E93 is required in the bract cell but not the bristle cell 
(Fig. III-2 B).  
E93 is required in the bract cell for the bract formation 
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Figure III-2: Mosaic clones show E93 is required in the bract cell 
A: Four possible genotype combinations of bristle and bract cells. I: black bract, black 
bristle. II: yellow bract, black bristle. III: black bract, yellow bristle. IV: yellow bract, 
yellow bristle. B: When E93Vnoe47 clones are marked by yellow, only wild-type black 
bracts are seen. C: If E93 is required in the bristle, then only black bristles will be able to 
induce bracts (either I or II). D: If E93 is required in the bract, then only black bracts will 
be present (either I or III).  
 
Since E93 is not required in the bristle, we shifted our attention to determining where E93 
acts in the EGFR signaling pathway in bract cells.  An important component of this 
pathway is Ras (Gilbert 2003).  Previous studies have shown that ectopic expression of 
activated Ras between 8-12 hr AP transforms most epidermal cells of the distal leg into 
bracts (del Alamo et al. 2002; Held 2002). When I drove expression of hs-RasV12 (a 
constitutively active form of Ras) between 18-22hr AP, extra bracts were induced (Fig. 
III-3 A).  However, when I heat shocked hs-RasV12 between 18-22 hr AP in an E93Vno 
mutant background, no bracts were induced (Fig. III-3 B), indicating that E93 lies 
downstream of Ras in the bract pathway. 
E93 is epistatic to Ras in bract formation 
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Figure III-3: Epistasis relationship of E93 and Ras 
A: Heat shock of hs-RasV12 between 18-22 hr AP induces extra outgrowths of epidermal 
cells that look like bracts.  B: Heat shock of hs-RasV12 between 18-22 hr AP in the 
E93Vnoe47 mutant background does not induce bracts, indicating that E93 is epistatic to 
Ras. 
 
A target of EGFR signaling in almost all contexts is the gene argos, which encodes a 
secreted antagonist of the Spitz EGFR ligand (Freeman et al. 1992; Schweitzer et al. 
1995).  To determine whether argos is also activated during bract induction, I examined 
expression of argos-lacZ in pupal legs.  LacZ expression was found to occur immediately 
proximal to each bristle in the pupal leg (Fig. III-4 A).  This observation suggests that the 
secretion of the Spitz ligand is polarized toward the proximal side of each bristle, 
accounting for why bracts develop only to the proximal side of bristles.  I then examined 
argos-lacZ expression in the E93Vnoe47 mutant background: lacZ expression was 
unaffected relative to E93+ animals (Fig. III-4 D).  This finding demonstrates that the 
EGFR signal transduction pathway is intact in E93Vno mutants, and suggests that E93 acts 
downstream of this pathway.  When I stained argos-lacZ pupal legs for both lacZ and 
E93 functions downstream of the EGFR signal transduction pathway 
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E93 expression, I found that the two co-localized to the same cells, which turn out to be 
pre-bract cells (Fig. III-4 C). 
 
Figure III-4: Relationship of E93 and Arogs 
A: argos-lacZ expression is detected proximal to each bristle in an argos-lacZ 
E93Df/TM6B pupal leg  (35-45 hr AP). B: E93 is also detected proximal to each bristle. C: 
A merged picture shows that lacZ and E93 co-localize to the same cells. D: argos-lacZ 
expression is intact in the E93 mutant background (argos-lacZ E93Df/E93Vnoe47). E: E93 
expression is strongly reduced in the E93 mutant background. F: Merged image.  
 
Dll is known to be expressed in bract-associated cells in newly emerged adults, and to be 
required for bract formation (Gorfinkiel et al. 1997; Campbell and Tomlinson 1998).  In 
Dll-Gal4; UAS-GFP newly emerged adults, GFP is expressed in bract-associated cells 
(Fig III-5 A).  However, in the E93Vnoe47/Df mutant background, GFP expression is not 
seen in these cells (Fig III-5 B), indicating that E93 lies upstream of Dll in the bract 
pathway.  I then  stained pupal legs for endogenous Dll protein, and found expression in 
cells located just proximal to each bristle (Figure III-5 D).  Double and triple labeling 
E93 acts upstream of Dll in bract formation 
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experiments demonstrated that Dll is expressed in the same cells as E93 and argos-lacZ 
Fig. III-5 D and Fig. III-6 C). When I stained for Dll expression in the E93Vnoe47 mutant, I 
found that bract expression of Dll was eliminated (Fig. III-5 G and Fig. III-6 F), 
indicating the E93 functions upstream of Dll in the bract pathway. 
 
Figure III-5: Epistasis relationship of E93 and Dll 
A: Dll-Gal4>UAS-GFP in a wild-type pupal leg; B: Dll-Gal4>UAS-GFP in a 
E93Vnoe47/Df pupal leg; C-E: A wild-type pupal leg stained for E93 and Dll; F-H: An 
E93Vno mutant leg (E93Vno/Df) stained for E93 and Dll; C, F: E93 expression; D, G: Dll 
expression; E, H: Merged images.  
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To confirm these experiments, I performed triple labeling with all three antibodies. In 
wild-type legs, all three proteins co-localize to the same cells. In the E93Vnoe47 mutant, 
E93 and Dll are reduced, but argos-lacZ staining is unaffected.  
 
 
Figure III-6: Relationship of Argos, E93, and Dll 
A-C: A wild-type pupal leg stained for argos-lacZ, E93, and Dll expression; D-F: An 
E93Vnoe47 mutant (E93Vnoe47/Df) pupal leg stained for argos-lacZ, E93, and Dll.; A, D: 
argos-lacZ expression; B, E: E93 expression; C, F: Dll expression. 
 
In most cases, EGFR signaling is executed by the transcription factor Pointed (Pnt). To 
determine whether Pnt is required for bract formation, we generated pnt- clones that were 
marked by yellow.  Such clones lack bracts.  Although black bracts can form adjacent to 
yellow or black bristles, yellow bracts are never seen, indicating that pnt+ is required 
within bract cells and not bristle cells (Fig. III-7 A).  I then examined pnt- clones (marked 
The temporal and spatial relationship of E93 and Pnt 
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by loss of GFP) in pupal legs by confocal microscopy.  In large pnt- clones both E93 and 
Dll expression are lost (Fig. III-7 D-G), indicating that both E93 and Dll lie downstream 
of pnt in the bract pathway.  In small pnt- clones, E93 and Dll expression are seen 
occasionally (Fig. III-7 H-K).  Presumably this expression is due to perdurance of Pnt in 
these clones. Although the expression of E93 and Dll are not affected in small clones, the 
positional pattern of transverse rows can be altered (compare the transverse row pattern 
in Fig. III-7 K with Fig. III-9 I). Since E93 is required for Dll expression (see above), 
these results position E93 between Pnt and Dll in the bract pathway. 
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Figure III-7: Pnt is required for the bract formation and functions upstream of E93 
and Dll 
A: pnt- clones in the leg lack bracts (classes I-IV are as explained in Fig. III-2 A); B: 
Over expression of Pnt.P1 between 12-24 hr AP induces extra bracts (red arrows); C: 
Over expression of Pnt.P1 between 24-60 hr AP eliminates bracts; D, H: pnt- clones are 
identified by the lack of GFP; E, I: E93 expression; F, J: Dll expression; G, K: merged 
images. The white outlines in D, E, F and G show the twin spots: the GFP positive spot is 
homozygous for pnt+, the GFP minus spot is homozygous for pnt-. 
 
 
When I over expressed UAS-pnt.P1 by heat shock, the effect on bract formation 
depended upon timing.  Heat shocks delivered between 12-24 hr AP caused ectopic 
bracts to form at the base of many bristles (red arrows Fig. III-7 B).  However, when heat 
shocks were administered at 24-60 hr AP, bract formation was suppressed (Fig. III-7 C). 
 
To explore the relationship between Pnt and E93 further, I obtained an antiserum raised 
against Pnt.P1 by Dr. James Skeath.  Double labeling with this antibody and anti-E93 
reveals that at 30 hr AP both E93 and Pnt co-localize to bract cells (white arrows in Fig. 
III-8 C).  However, in later pupae (35 hr AP), Pnt expression is reduced in bract cells (i.e. 
E93-expressing cells) but becomes elevated in two cells flanking the bract cell (white 
arrows in Fig. III-8 F and Fig. III-9 I).  This temporal change in expression correlates 
with the stage specific effects of Pnt.P1 ectopic expression.  In the early pupa, Pnt is 
expressed in the future bract cell, where it activates E93 expression.  Ectopic expression 
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of Pnt.P1 at this time induces ectopic bract formation (Fig. III-7 B).  Later, when Pnt is 
down regulated in bract cells, bracts are repressed by ectopic Pnt.P1, perhaps because Pnt 
now represses E93 (Fig. III-7 C).  
 
 
 
Figure III-8: The temporal specific positional relationship of Pnt and E93 
A-C: The distal tibia of a wild-type first thoracic leg at 30 hr AP; D-F: The distal tibia of 
wild-type first thoracic leg at 35 hr AP; A, D: Pnt expression; B, E: E93 expression; C, F: 
merged images. 
 
Not all bristles develop bracts in the leg.  For example, the prominent transverse rows of 
bristles present in the distal part of the tibia of the first leg do not develop bracts, whereas 
transverse rows of bristles in the basitarsus do (Fig. III-9 B, Tokunaga and Stern 1965 
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Tokunaga 1962).  By 35 hr AP, E93 expression is mostly lost from these transverse rows 
in the distal tibia, whereas Pnt expression is maintained (white arrow heads in Fig. III-8 F 
and Fig. III-9 F).  In contrast, E93 expression is sustained in cells of the future transverse 
rows in the basitarsus, whereas Pnt expression is reduced in these cells and elevated in 
adjacent cells (white arrows in Fig. III-9 I). The continued expression of Pnt in cells that 
lose E93 expression, and the repression of Pnt in cells that maintain E93 expression, 
suggest that E93 or Dll may repress pnt at 35 hr AP.  
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Figure III-9: The positional relationship of E93 and Pnt 
A: Junction area of the tibia and basitarsus of the first leg of the fly. Transverse rows in 
the distal tibia have no bracts, but the transverse rows in the basitarsus do. B: Schematic 
summary of bristles and bracts in the distal tibia and basitarsus of the first leg (Tokunaga 
1962; Tokunaga and Stern 1965 ). Circles represent bristles, triangles represent bracts, 1-
8 represent longitudinal bristle rows, transverse rows (t), preapical bristle (PA), apical 
bristle (A), central bristle (C), sex comb (SC). C: A merged picture of pupal leg (34-36hr 
AP) with Pnt and E93 expression. D-F: The enlarged distal tibia area in C. G-I: The 
enlarged basitarsus area in C. 
 
To determine the relationship between E93 expression and cells of the bristle lineage, I 
examined the neuralized enhancer trap A101, which is expressed in sensory organ 
precursor cells and their descendants (Huang et al. 1995).  By 35 hr AP, sensory organ 
precursor cells have divided so that A101 is expressed in clusters of 3 or 4 cells (Fig. III-
10 A). Double labeling reveals that E93 is expressed strongly in one of these cells, and 
weakly in an A101 positive cell lying just distal (cell B and cell A in Fig. III-10 N).  This 
observation is surprising, as clonal analysis experiments show clearly that bracts are not 
related by lineage to bristle cells (e.g. Fig. III-2 A).  Therefore, one would not expect E93 
to be expressed in cells of the sensory organ precursor lineage.  One possibility is that 
A101 expression in the strongly positive E93 cells is induced by neighboring A101 
positive cells.  The possibility of such induction has been raised previously (Huang et al. 
1995).  Pnt is expressed weakly in the E93 positive cell (cell 2 in Fig. III-10 O), but 
The relationship of E93 and bristle precursor cells 
 44 
strongly in two flanking cells (cell 4, 5 in Fig. III-10 O).  In the first leg transverse row 
bristle rows that have no bracts, E93 expression is dramatically reduced (cell A, B in Fig. 
III-10 N), whereas Pnt expression remains high (cell B in Fig. III-10 O). 
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Figure III-10: The positional relationship of E93, Pnt, and A101 expression in 35hr 
AP legs 
A-D: A wild-type leg at 35 hr AP; E-H: enlarged view of the white box on the left in D; 
I-L: Enlarged view of the white box on the right in D; M-P: Schematic summary of 
protein expression profile of bristles with or without bracts; cells 1-5 will give rise to 
bristles with bracts; cells A-E will give rise to bristles without bracts;  A, E, I, M: A101 
expression; B, F, J, N: E93 expression; C, G, K, O: Pnt expression; D, H, L, P: Merged 
images. 
 
Double labeling experiments reveal that Dll has the same temporal and spatial expression 
pattern as E93: Dll co-localizes with E93 in the future bract cell (arrow heads in Fig. III-
11 D, H), and at 35 hr AP is flanked by cells expressing Pnt (Fig. III-11 L).  In addition, 
Dll is repressed in transverse rows that do not develop bracts (arrows in Fig. III-11 D), 
but expressed in transverse rows that do develop bracts (arrows in Fig. III-11 H).  
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Figure III-11: The positional relationship of Pnt, E93, Dll, and A101 expression 
A-L: Wild-type legs at 35hr AP; A-D: Distal tibia of the first leg; E-H: Basitarsus of the 
first leg; I-L: Regular bristles with bracts; A, E, I: A101 expression; B, F: E93 expression; 
J: Pnt expression; C, G, K: Dll expression; D, H, L: Merged images. 
 
The finding that E93 is expressed specifically in bract cells and lies between pnt and Dll 
in the bract pathway raises the possibility that the role of E93 in bract formation is quite 
distinct from its role as an ecdysone response gene.  To determine whether ecdysone 
signaling is required for bract formation, I reduced ecdysone receptor activity by RNAi 
(targeting a common fragment of all EcR isoforms, Colombani et al. 2005) in mosaic 
Ecdysone signaling is required for bract formation 
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clones (in y w FLP; Act>y+>Gal4 UAS-GFP/UAS-EcR-RNAi).  Bracts are reduced in 
size or absent in the ecdysone receptor RNAi clones (marked by yellow), indicating that 
ecdysone signaling is involved in bract formation (Fig. III-12 A). To determine whether 
loss of ecdysone receptor activity also causes loss of E93 and Dll expression in bract cells, 
I examined the E93 and Dll expression in EcR knock down clones (marked by GFP 
positive cells). Preliminary data show that E93 and Dll are still expressed robustly in EcR  
knock down clones.  Additional work will be required to determine whether these clones 
have no effect on E93 expression because EcR is not required for E93 bract expression, 
or because of perdurance or incomplete knock down of EcR. 
 
 
Figure III-12: Ecdysone signaling is involved in bract formation 
A: Most bracts are eliminated in the ecdysone receptor knock down clones (marked by 
yellow); B: EcR knock down clones are marked by GFP positive cells; C: E93 expression; 
D: Dll expression; E: Merged images. 
 
Is expression of E93 instructive or permissive in bract formation? 
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At the outset of my work on bracts, my hypothesis was that E93 provides a temporal 
signal that facilitates activation of Dll in bract cells by other spatially restricted 
transcription factors (presumably Pnt).  The finding that E93 itself is restricted in 
expression to bract cells very much clouded the situation.  Is spatially restricted 
expression of E93 important for bract specification? To answer this question, I generated 
clones that ectopically express E93 in an E93Vnoe47 mutant background leg.  The GAL80ts 
method (McGuire et al. 2004) was used to restrict ectopic expression in these clones to 
the pupal stage. When such clones are generated in an E93Vnoe47 mutant background, bract 
development is often fully rescued proximal to bristles, but ectopic bracts are never seen 
(Fig. III-13).  This result demonstrates that spatially restricted expression of E93 is not 
required for bract formation, and that E93 plays a permissive, not instructive, role in bract 
formation.  Such a permissive role is consistent with our hypothesis that E93 provides 
primarily temporal rather than spatial information during bract formation. 
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Figure III-13: E93 expression is permissive in bract formation 
E93 is ectopically expressed in E93Vnoe47 mutant background by UAS-E93-ORF clones 
(marked by yellow in y w FLP12; Act>y+>Gal4 UAS-GFP/UAS-E93-ORF; tub-Gal80ts 
E93Df/ E93Vnoe47 animals).  Bracts are formed proximal to bristles, but not elsewhere in 
the clone.  
 
Discussion 
My experiments establish that E93 lies downstream of pnt and upstream of Dll in the 
bract induction pathway.  The key lines of evidence that support these conclusions are:  1) 
mosaic studies demonstrate that E93 is required within the bract cell, 2) argos-lacZ is 
activated normally in bract cells in E93Vno mutants, indicating that E93 acts downstream 
of the EGFR signal transduction pathway, 3) pnt- clones lose bract expression of E93, 
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indicating that E93 lies downstream of pnt, and 4) E93Vno clones lose expression of Dll in 
bract cells, indicating the E93 lies upstream of Dll in the bract pathway.   
 
Is the bract pathway a simple linear pathway in which pnt activates E93, which then 
activates Dll?  The results of my E93 ectopic expression experiment would argue not.  In 
this experiment, I demonstrated that leg clones expressing E93 in an otherwise E93Vno 
mutant background rescue bracts in their normal location proximal to bristles, but do not 
induce ectopic bracts.  This result indicates that although E93 expression is normally 
restricted to bract cells, this spatial restriction is not essential for normal bract 
development.  That is, E93 plays a permissive, rather than instructive, role in bract 
specification.  A very different result was obtained for Pnt: ectopic expression of Pnt at 
12-24 hr AP does cause ectopic bract development, indicating that bract position is 
defined by spatially restricted pnt activity.  These observations suggest that E93 and Pnt 
have distinct inputs to Dll activation, with Pnt providing spatial information and E93 
providing temporal information.  A model for the bract pathway in which Dll is activated 
by the combined action of E93 and Pnt is presented in Figure III-14. 
 
The ectopic bracts produced by ectopic Pnt expression are all very near to normal bracts.  
Why aren't bracts produced indiscriminately by ectopic Pnt?  Pnt is activated by 
phosphorylation as a result of the activity of the EGFR signal transduction pathway.  
When Pnt is expressed ectopically, presumably its activity is still restricted to the vicinity 
of the normal bracts because only here is it properly phosphorylated.  When activity of 
the EGFR pathway itself is activated ectopically, bracts are in fact induced everywhere in 
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the leg (Fig. III-3 A, del Alamo et al. 2002; Held 2002). An unexpected feature of Pnt 
expression is that although Pnt is initially expressed in the bract cells, in later pupae it 
becomes partially repressed in these cells and activated in two flanking cells.  The basis 
of this transition has not been determined.  The loss of Pnt expression from the bract cell 
may result from repression by E93 or Dll.  The activation of Pnt in the two flanking cells 
implies that these cells have received EGFR signals, but the origin of these signals is not 
clear.  As described above, ectopic expression of Pnt in later pupae represses bract 
development, suggesting that Pnt may transition from an activator to a repressor of E93 
as pupal development proceeds (Fig. III-7 C).  
 
An additional feature established in my work is that bract development is dependent upon 
ecdysone signaling.  Although I do not know where ecdysone signaling enters into the 
bract pathway, it seems likely that it is required for proper E93 expression or activity (see 
Fig. III-14).    
 
A second unresolved feature of bract development is that E93 and Dll are activated in 
cells that also express the A101 enhancer trap.  This reporter labels sensory organ 
precursor cells and their mitotic descendants.  Since bracts are clearly not related by 
lineage to bristles, the coexpression of A101, E93 and Dll is surprising.  One possible 
explanation is that A101 expression in bract cells is induced by adjacent A101 positive 
cells.  Future work will be required to resolve this issue. 
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Figure III-14: A model for bract induction 
In this model, bristle cell sends out EGFR ligand (green arrow) to activate the EGFR 
signaling pathway in an epidermal cell located at the proximal part of the bristle cell. 
Thus the activation of EGFR signaling provides the spatial information required for bract 
induction. In addition, ecdysone and EcR complex induce E93 expression during 
metamorphosis, which provides the temporal information required for bract induction. 
The inputs from both Pnt and E93 ensure the activation of Dll at the appropriate time and 
space. The green arrow represents the EGFR ligand sent out from the bristle cell. Dotted 
lines indicate that other genes are omitted from the pathway.  
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Chapter IV : Complementation of the E93Vno alleles and E931, E932, and E933; are 
the larval cell death and imaginal patterning functions of E93 executed by different 
protein domains? 
 
Abstract 
As described in Chapter I, the E93Vno alleles are defective in many imaginal patterning 
processes during metamorphosis, whereas the E931, E932, and E933 alleles are defective 
in larval cell death during metamorphosis.  These two groups of alleles fully complement 
one another.  To understand this complementation, I first asked whether each allele type 
is defective in just one or the other function. Because the E931, E932, and E933 alleles all 
cause death prior to imaginal disc differentiation, I assessed their effects on imaginal 
patterning by generating homozygous mutant clones.  All of these alleles produce normal 
cuticular patterns in clones, indicating they all are fully functional in imaginal patterning. 
Eric Baehrecke's group has examined larval cell death in hemizygotes for the E93Vno 
alleles: all show near normal salivary gland cell death early in metamorphosis.  Why do 
the two groups of alleles affect specifically one function or the other?  The imaginal 
patterning function presents few problems; E931 is associated with a nonsense change at 
codon 995, and likely complements the E93Vno alleles because the large N-terminal 
fragment of E93 it encodes is sufficient to execute all imaginal patterning functions.  
Sequence changes have not been identified for E932 and E933 (Lee et al. 2000), but 
heterozygotes for these alleles and E93Vnoe47 show almost normal E93 expression in 
imaginal tissues, suggesting that these alleles affect regulatory regions specific for larval 
cells.  In contrast, the ability of the E93Vno alleles to drive larval cell death has been 
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difficult to rationalize.  These alleles truncate the E93 coding sequence N terminal to 
E931, and encode E93 fragments lacking all or part of the pipsq DNA-binding domain.  I 
have considered two explanations.  First, the activation of larval cell death may require 
only a specific domain within the E93 protein.  To test this possibility, I generated UAS 
constructs that express fragments of the E93 (see below).  Second, larval cell death may 
be activated by previously undescribed products of the E93 locus.  This possibility is 
explored in Chapter V. 
 
Rationale 
The complementation of the E93Vno alleles and E931, E932, and E933 has been difficult to 
explain.  In this chapter I show that the E931, E932, and E933 alleles affect larval cell 
death specifically, and are fully capable of executing the imaginal patterning functions of 
E93.  Conversely, the E93Vno alleles are defective in imaginal patterning, but are almost 
fully capable of executing the larval cell death functions of E93 (Dutta and Baehrecke, 
personal communication).  Although it is easy to rationalize why the E931, E932, and 
E933 alleles are able to function in imaginal patterning, it has been difficult to understand 
why the E93Vno alleles are able to function in driving larval cell death.  One possibility is 
that only a portion of the E93 protein is required for the cell death function.  In this 
chapter, I test this possibility by driving ectopic expression of subfragments of E93.   
 
Methods 
The generation of E93 UAS constructs 
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I designed six E93 UAS constructs: UAS-ORF, UAS-Clone2, UAS-E931Nterm, UAS-
E93Vnoe47Nterm, UAS-E93Vnoe47Cterm, and UAS-Δpipsq (Fig. IV-1).  All fragments were 
amplified from “LP library F211 pBluescript SK-” (the Clone2 cDNA I obtained from 
cDNA screening - see Chapter V).  Primers were designed so that a consensus translation 
initiation sequence in Drosophila (CAAC) was present at the beginning of each ORF.  
Each E93 fragment was subcloned into PCR8/GW/TOPO entry clone by 
PCR8/GW/TOPO TA cloning kit (Invitrogen, Cat # k2500-20), and then recombined into 
pTW destination vector for injection (primers used to generate each fragment and 
sequence information for each fragment is included in the Appendix). The UAS-LP0 
construct was constructed by Dianne Duncan using the pUAST vector. The UAS-
E93(Baehrecke) construct was made by Eric Baehrecke, and was cloned into the pUAST 
vector (Lee et al. 2000). 
 
UAS-E93(Baehrecke): E93 full length ORF from Dr. Eric Baehrecke. Although my 
sequencing shows that the normal initiating ATG is absent from this construct, 
antibody staining (see below) indicates that this construct is translated, presumably 
using an alternate ATG.  
UAS-ORF: E93 full length ORF 
UAS-Clone2: E93 full length ORF with leading sequence of clone2 
UAS-LP0: LP0 full length ORF with leading sequence of LP0 
UAS-E931Nterm: E93 ORF truncated at the position of the E931 nonsense mutation 
(codon 995) 
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UAS-E93Vnoe47Nterm: E93 ORF truncated at the position of E93Vnoe47 nonsense mutation 
(codon 360) 
UAS-E93Vnoe47Cterm: E93 ORF starting from the first in frame ATG after the E93Vnoe47 
mutation (codon 371 ) 
UAS-Δpipsq: E93 ORF with a deletion of codons 750-898.  This deletion removes the 
pipsq DNA-binding domain (codons 761-814) and surrounding sequences.  The 
deletion is bigger than the conserved pipsq domain because of my miscalculation 
 
 
Figure IV-1: Molecular map of E93 transcripts, mutants, UAS-E93 constructs and 
E93 antigen 
The boxes represent exons, and shaded areas represent the predicted coding regions. The 
transcript inferred by Baehrecke is in red, the LP0 transcript is in green, and the Clone2 
transcript is in yellow.  Black arrows indicate the stop codon positions of the E93Vnoe47, 
E93Vnoe31, E93Vnoe18, and E931 mutations, respectively. The black triangles are insertions 
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of two Doc elements and a P-element in the E93Vnol(3)ry93 allele. The E93 UAS constructs 
are indicated in gray. Coding regions used for antibody production are in blue. 
 
I built two groups of stocks.  In one group, I included a Gal4 driver (dpp-Gal4, fkh-Gal4, 
or act>y+>Gal4), a temperature-sensitive Gal4 repressor (tub-Gal80ts), a clone marker 
(UAS-GFP), and E93Df.  In the other group, I included one of the UAS-E93 constructs 
together with E93vnoe47 or E931. 
Stock construction: 
Gal4 driver stocks  
fkh-Gal4 w; tub-Gal80ts  UAS-GFP; fkh-Gal4 E93Df /TM6B  
dpp-Gal4 w; tub-Gal80ts  UAS-GFP; dpp-Gal4 E93Df/TM6B  
act>y+>Gal4 yw FLP; act>y+>Gal4 UAS-GFP; tub-Gal80ts 
E93Df/TM6B  
 
E93 UAS construct stocks  
UAS-E93 (Baehrecke) 
UAS-E93-ORF (line A1) 
UAS-E93-clone2 (line B2) 
UAS-E93-LP0 (line I2e) 
UAS-E931Nterm (line D1) 
UAS-E93Vnoe47Nterm (line H1) 
UAS-E93Vnoe47Cterm (line A2) 
UAS-E93-Δpip (line A3) 
 
 
w; UAS-E93-X; E93e47/TM6B 
 
 
w; UAS-E93-X; E931/TM6B 
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Clones homozygous for E931, E932, or E933 were generated by crossing y w FLP122; 
FRT82B CD2 y+ M(3)W Bsb / TM6B  ♀ with FRT82B cu E931/2/3 ca / TM6B ♂, and then 
heat shocking progeny larvae at 37˚C for 30min. Homozygous E93 -mutant clones were 
identified in non-Tubby progeny and were recognized by their long bristles in both ♀ and 
♂, or by their long bristles and yellow cuticle in ♂ flies. 
Other stocks and methods: 
 
Acridine Orange Staining: imaginal discs are stained in 1.6 uM freshly prepared Acridine 
Orange solution for 5 min, rinsed with Ringer’s solution, and mount in Ringer’s solution 
for immediate examination.  
 
Results: 
As described above, the E93Vno mutants are defective in numerous imaginal patterning 
processes that take place during metamorphosis.  Since homozygotes for E931, E932, or 
E933 die at the early pupal stage, I assessed the ability of these mutants to execute 
imaginal patterning by generating homozygous mutant clones.  All three alleles show 
normal patterning in such clones: no patterning defects are found in the leg, the eye, the 
antenna, the arista or the abdominal tergites (Fig. IV-2 B-E), all of which show abnormal 
phenotypes in the E93Vno mutants.  These findings demonstrate that E931, E932, and E933 
are not defective in the imaginal patterning functions of E93.  
E93Vno alleles and E931/2/3 alleles are normal in the function that is defective in the other 
complementation group 
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Figure IV-2: E931/2/3 alleles are normal in imaginal patterning function 
A: An E93Vnoe47 mutant clone; this is a positive control to show that there are no bracts in 
E93Vnoe47 mutant clones; B-E: E931 mutant clones in the leg, eye, antenna, and abdomen; 
Clone boundaries in A, B, C, and E are indicated in red. The red arrow in D indicates an 
E931 antenna; the other antenna is heterozygous for the markers M(3)w and Bsb, which 
cause a reduction in bristle size and in the aristal branches.  E932 and E933 clones behave 
identically.  
 
Baehrecke's group has shown that the E931, E932, and E933 mutants are all defective in 
the death of larval cells in the midgut and salivary gland during metamorphosis (Lee et al. 
2000).  In wild-type pupae, salivary glands are completely degraded by 24hr AP, whereas 
in hemizygotes for E931, E932, or E933, salivary glands remain intact at this time (Table 
IV-1, personal communication from Baehrecke’s lab).  For her thesis work, Sudeshna 
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Dutta (a graduate student in Eric Baehrecke's lab) examined salivary gland death in 
selected E93Vno genotypes.  Her results are reproduced in Table IV-1.  Hemizygotes for 
the E93Vnoe31 and E93Vnoe18 alleles show mildly impaired salivary gland death, with 90 - 
100% of 24 hr AP pupae showing absence or fragmentation of salivary glands.  Curiously, 
the three heterozygous combinations of the E93Vno alleles and the one homozygote 
examined (E93Vnoe31/E93Vnoe31) show a more severe phenotype, with no pupae showing 
complete loss of salivary glands at 24 hr AP, 29%-66% showing salivary gland 
fragmentation, and 34 - 71% showing intact salivary glands. The weak phenotypes seen 
in hemizygotes indicate that the E93Vno alleles are only weakly impaired in the cell death 
function, but the stronger phenotypes shown by the homozygous or heteroallelic 
genotypes suggest that the E93Vno alleles encode proteins that actively interfere with the 
cell death function.  
 
Table IV-1: The percent of 24 hr AP pupae with the indicated salivary gland 
phenotypes 
 (n> 20 pupae/genotype) (personal communication from Sudeshna Dutta and Dr. Eric 
Baehrecke) 
Genotype 
Intact/condensed 
salivary glands 
Fragmented 
salivary glands 
No glands 
E93Vnoe18/+ 0 20 80 
E931/Df 100 0 0 
E93Vnoe18/Df 10 40 50 
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E93Vnoe31/Df 0 35 65 
E931/E93Vnoe18 13 20 67 
E93Vnoe18/E93Vnoe31 71 29 0 
E93Vnoe31/E93Vnoe47 54 46 0 
E93Vnoe47/E93Vnoe18 34 66 0 
E93Vnoe31/E93Vnoe31 36 64 0 
 
The larval midgut 
E93 expression in complementing heterozygotes: 
E93Vno/Df animals (E93Vnoe18/Df , E93Vnoe31/Df, and E93Vnoe47/Df) show a strong reduction 
in E93 staining in the midgut around 1-5hr AP(Fig. IV-3 B, C, D), despite showing near-
normal salivary gland apoptosis (personal communication from Baehrecke’s lab). 
E931/Df, E932/Df, and E933/Df animals also show a strong reduction in E93 staining in 
the 1-5 hr AP midgut (Fig. IV-3 E, F, G).  I also examined E93 staining in heterozygotes 
for the E93Vnoe47 allele and E931, E932, and E933.  E93Vnoe47/E931 heterozygotes show 
very little E93 staining in the 1-5 hr AP midgut.  In contrast, almost normal E93 staining 
is seen in the 1-5 hr AP midgut in E93Vnoe47/E932 and in E93Vnoe47/E933 heterozygotes 
(Fig. IV-3 I, J).  The latter results are striking because neither E93Vnoe47 nor the E932 or 
E933 mutants show much staining in midgut cells on their own when hemizygous.  One 
possibility is that E932 and E933 are mutations in larval-cell specific enhancer(s), and that 
the normal larval enhancers carried by the E93Vnoe47 allele can act in trans to activate 
expression of the intact E93 coding region from the E932 and E933 alleles.  Such trans 
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action of enhancers (transvection) has been described for several other genes in 
Drosophila.  Although transvection may help account for the ability of the E93Vno alleles 
to complement E932 and E933, transvection cannot explain the complementation of these 
alleles with E931, nor can it explain why the E93Vno alleles are able to execute near-
normal larval cell death on their own. 
 
Imaginal patterning 
The ability of the E932 and E933 alleles to execute the imaginal patterning functions of 
E93 is consistent with the expression of E93 protein in heterozygotes of these alleles and 
E93Vno alleles.  E93Vno/Df animals (E93Vnoe18/Df , E93Vnoe31/Df, and E93Vnoe47/Df) show a 
strong reduction in E93 staining in bract cells in pupal legs (Fig. IV-3 B’, C’, D’).  
However, E932/E93Vnoe47 and E933/E93Vnoe47 heterozygotes show almost normal levels of 
E93 expression in bract cells (Fig. IV-3 I’, J’).  This result suggests that the E932 and 
E933 mutations may be defective specifically in larval cell expression.  The E931 allele (a 
nonsense change at codon 995) behaves differently: E931/E93Vnoe47 heterozygotes show 
some staining of E93 in pupal legs, but it is not as strong as in E932/E93Vnoe47 or 
E933/E93Vnoe47 heterozygotes (Fig. IV-3 H’).  One possibility is that the large N-terminal 
fragment encoded by E931 is competent to execute the imaginal patterning functions of 
E93, even when present at low levels.  
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Figure IV-3: Expression of E93 in different allelic combinations during 
metamorphosis  
A-J: Midgut at 1-5hr AP; A’-J’: Pupal leg at 30-50hr AP; A & A’: Wild-type; B & B’: 
E93Vnoe18/Df; C & C’: E93Vnoe31/Df; D & D’: E93Vnoe47/Df; E: E931/Df; F: E932/Df 
(coming soon); G: E933/Df; E, F and G genotypes were not survive to late pupal stage, so 
E’, F’ and G’ are Not Available (N/A); H &H’: E93Vnoe47/E931; I & I’: E93Vnoe47/E932; J 
& J’: E93Vnoe47/E933.  
 
Generation of UAS constructs 
The execution of imaginal patterning function and larval cell death function 
To test whether specific subdomains of E93 are responsible for the imaginal patterning 
and cell death functions of the locus, I generated UAS constructs that express fragments 
of the E93 coding sequence (see Methods).  I also generated constructs expressing 
alternate transcripts from the locus. The molecular maps of the UAS constructs I 
examined are summarized in Fig. IV-1. To make sure that the constructs I produced are 
capable of being expressed, I tested each transformant line by crossing it to en-Gal4 and 
staining the progeny embryos for E93 expression.  All eight constructs analyzed produce 
striped embryos, indicating that the constructs are correct and have been engineered into 
transformants successfully (Fig. IV-4).  
 65 
 
Figure IV-4: Expression of E93 UAS constructs in embryos when driven by en-Gal4 
A: UAS-E93(Baehrecke); B: UAS-ORF A1 line: C: UAS-clone2 B2 line; D: UAS-LP0 
I2e line; E: UAS-E931Nterm D1 line; F: UAS-E93Vnoe47Nterm H1 line; G: UAS-
E93Vnoe47Cterm A2 line; H: UAS-Δpipsq A3 line; A-H are all stained by E93 antibody 
from rabbit B, except F, which is stained by E93 antibody from mouse 5. 
 
Imaginal patterning function 
My work to test the ability of the UAS constructs to rescue the imaginal patterning 
functions of E93 has only just begun.  The one result I have is described in Chapter III: in 
this experiment I showed that clones expressing the UAS-ORF construct during pupal 
development in E93Vnoe47 mutants are able to rescue bract formation proximal to bristles 
in the legs, but do not cause additional cells in the leg to become bracts (Fig. III-13).  
This observation demonstrates that E93 plays a permissive rather than instructive role in 
bract formation.  Tests of the rescue ability of the other UAS constructs are in progress. 
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Larval cell death function 
It has been difficult to understand why the E93Vno mutants are almost fully competent to 
drive larval cell death.  All three of these mutations are nonsense alleles that truncate the 
coding sequence N-terminal to the E931 allele, which is defective in larval cell death.  
They also lie N-terminal to the pipsq DNA binding domain.  One possibility is that the 
portion of the protein N-terminal to the 5'-most of the E93Vno truncations (E93Vnoe47) is 
capable of executing the cell death function.  Another possibility is that translation 
reinitiation occurs subsequent to termination at the E93Vno nonsense changes, so as to 
produce C-terminal fragments of E93 capable of executing the cell death function.   
   
As an initial test of these possibilities, I drove expression of each UAS construct using 
fkh-Gal4, which is expressed in salivary glands in the embryo and larva (Henderson and 
Andrew 2000; Berry and Baehrecke 2007). Although there was some variation among 
different lines tested for each construct, in general, each construct had a consistent effect.  
The results are summarized in Table IV-2.  Salivary glands were absent in late larvae 
when fkh-Gal4 was combined with the full length variants UAS-ORF, UAS-Clone2, and 
UAS-LP0.  Expression of the full-length construct UAS-E93 (Baehrecke) did not cause 
ablation of salivary glands, but I have shown that this construct has an introduced 
mutation in its initiating ATG.  Among the partial E93 constructs tested, UAS-
E931Nterm and UAS-E93Vnoe47Cterm caused deletion of salivary glands, but UAS-
E93Vnoe47Nterm and UAS-E93-Δpipsq did not.  If we assume that larval salivary gland 
ablation is a good proxy for the larval cell death function of E93, then the finding that 
UAS-E93Vnoe47Nterm does not affect salivary glands argues that the normal larval cell 
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death seen in E93Vnoe47 mutants is not due to activity of the N-terminal nonsense fragment 
encoded by this mutation.  The finding that UAS-E93Vnoe47Cterm does cause deletion of 
salivary glands suggests that larval cell death in E93Vnoe47 mutants may be executed by a 
C-terminal fragment of E93 produced by translation reinitiation.  The finding that UAS-
E931Nterm causes salivary gland ablation was surprising because salivary gland death is 
defective in E931 mutants, which presumably produce this fragment endogenously.  A 
likely explanation is that this fragment is produced at higher levels in fkh-Gal4/UAS-
E931Nterm heterozygotes than in E931 mutants.  The complete lack of effect of UAS-
E93-Δpipsq suggests that the DNA-binding pipsq domain is essential for the cell death 
functions of E93. 
 
Table IV-2: The effects of UAS-E93 constructs when expression driven by fkh-Gal4  
 Observed salivary gland 
UAS-E93 (Baehrecke) present 
UAS-ORF deleted 
UAS-E93-Clone2 deleted 
UAS-E93-LP0 deleted 
UAS-E931Nterm deleted 
UAS-E93Vnoe47Nterm present 
UAS-E93Vnoe47Cterm deleted 
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UAS-E93-Δpipsq present 
 
However it is not clear that the loss of larval salivary glands is a valid assay for the larval 
cell death function of E93.  To determine whether E93 can cause death of imaginal cells, 
I drove UAS-LP0 by dpp-Gal4 in larvae and used tub-Gal80ts to control the timing of 
expression.  Acridine orange staining after 22 hr of expression revealed cell death 
induction along the compartment boundaries of the imaginal discs, whereas the wild-type 
control group had much less cell death in discs (Fig. IV-5). Thus, it is possible that the 
deletion of salivary glands in fkh-Gal4>UAS-E93 constructs is caused by cell death as 
well. 
 
 
Figure IV-5: UAS construct causes cell death in imaginal discs 
A: Wild-type wing disc; B: dpp-Gal4>UAS-LP0 expressed in a wing disc for 22hrs; C: 
Wild-type leg disc; D: dpp-Gal4>UAS-LP0 expressed in a leg disc for 22hrs; A-D: dpp-
Gal4 is repressed by tub-Gal80ts during embryonic and early larval stages, and activated 
in 3rd instar larvae. All discs stained with acridine orange. 
 
To look directly for a C-terminal fragment encoded by the E93Vnoe47 mutant, I took 
advantage of the antigen specificity of the E93 antibodies produced by Mouse 5 and 
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Mouse 6.  The Mouse 5 antibody was raised against antigen II, which is in the N-terminal 
half of the coding sequence, whereas the Mouse 6 antibody was raised against antigen III, 
which is in the C-terminal half (Fig. II-1 I, L and Fig. IV-1).  If the larval cell death 
function in the E93Vnoe47 mutant is executed by a C-terminal fragment of E93 produced 
by translation reinitiation, then this protein should be detected by the antibody from 
Mouse 6, but not from Mouse 5.  The result was that neither antibody detected any signal 
in the 2hr AP midgut or 13hr AP salivary gland (Fig. IV-6 C, D, G, H) of E93Vnoe47 
mutants.  Even the rabbit antibody raised against all three antigens failed to detect any 
signal (Fig. IV-6 B, F).  If a C-terminal fragment is produced in the E93Vnoe47 mutant, it is 
in amounts below detection by our antibodies. 
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Figure IV-6: The relationship of E93 functional domain and the execution of larval 
cell death 
A-D: 2hr AP midgut; E-H: 13hr AP salivary gland; A, E: Wild-type animal; B-D, F-H: 
E93Vnoe47/Df mutant; A, B, E, F: stained using antibody from Rabbit B; C, G: stained 
using antibody from Mouse 5; D, H: stained using antibody from Mouse 6. 
 
Discussion 
In this chapter I attempt to understand the complementation of the E931, E932, and E933 
alleles, which are defective in larval cell death, and the E93Vno alleles, which are 
defective in many imaginal patterning processes during metamorphosis.  In my work, I 
showed that clones of cells homozygous for E931, E932, or E933 show completely normal 
imaginal patterning, demonstrating that these alleles are defective only in driving larval 
cell death.  Conversely, Baehrecke's group has shown that the E93Vno mutants show near 
normal larval cell death, indicating that these alleles more or less specifically affect the 
imaginal patterning function of E93.  Given that these two groups of alleles affect 
different functions of E93, their ability to complement clearly does not require a special 
interaction between alleles such as transvection or trans-splicing. Rather, the problem lies 
in understanding why the two groups of alleles specifically affect primarily one or other 
function. 
 
The requirements for the imaginal patterning function of E93 seem fairly straightforward:  
The E93Vno alleles are nonsense changes N-terminal to or within the pipsq DNA-binding 
domain, suggesting that imaginal patterning is executed by the E93 protein first defined 
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by Baehrecke's group.  Antibody stainings suggest that the E932 and E933 alleles express 
this protein properly in imaginal tissues, accounting for the ability of these alleles to 
complement the E93Vno alleles.  The E931 allele likely complements the E93Vno alleles 
because the large N-terminal fragment it encodes (which contains amino acids 1 - 994 
and includes the pipsq domain) is sufficient to execute the imaginal patterning functions 
of E93.   
 
The requirements for the larval cell death function of E93 are much less clear.  A major 
impediment has been that sequence changes have not been identified for the E932 and 
E933 alleles; neither affects the known coding sequences of E93.  Possibly, these alleles 
affect regulatory sequences required for expression in larval cells. The E931 allele does 
affect the coding sequence (it is a nonsense change at codon 995).  This allele causes 
dramatically reduced expression of E93 in imaginal and larval cells, likely because it 
causes nonsense-mediated decay (reviewed in Wen and Brogna 2008) of E93 transcripts.  
This reduced expression is likely responsible at least in part for the loss of larval cell 
death in this mutant, since expression of the E931 N-terminal fragment driven by the 
UAS system causes the ablation of larval salivary glands.  
 
The ability of the E93Vno mutants to execute the larval cell death function is particularly 
difficult to explain.  My finding that expression of the N-terminal fragment encoded by 
the E93Vnoe47 allele does not ablate larval salivary glands suggests that this fragment 
cannot drive cell death.  My finding that the coding sequence C-terminal to the E93Vnoe47 
truncation does cause larval salivary gland ablation suggests that translation reinitiation 
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in this mutant might produce an E93 C-terminal fragment capable of driving larval cell 
death.  However, such a reinitiation product was not identified by antibody staining.  
Perhaps the level of protein expression is too low to be detected by our staining, or 
translation reinitiation is in a different reading frame, and therefore not detectable by our 
antibodies.  Taken together, these observations raise the possibility that the larval cell 
death function of E93 may be executed by a novel product or products from the locus.  In 
Chapter V, I describe my search for such products. 
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Chapter V : Search for alternate products from E93 
 
Abstract 
Northern blotting, RTPCR, cDNA screening, and Ribonuclease Protection Assays (RPA) 
were used to search for alternate transcripts of E93 that might function specifically in its 
larval cell death or imaginal patterning functions. Northern blotting confirmed the 
presence of the 9.5kb E93 transcript described by Baehrecke and Thummel (1995). The 
LP0 transcript was also confirmed, but this RNA and the E93 RNA are expressed in both 
larval and imaginal cells, indicating neither is specific for imaginal patterning or larval 
cell death.  I identified a novel E93 transcript (called clone2) by cDNA screening, but it 
contains the same coding region as E93. Using probes from the 3' portion of the E93 
coding region, I also detected three small polyadenylated transcripts on Northern blots.  
These RNAs appear just prior to salivary gland cell death, suggesting they may be 
involved in executing larval cell death.  However, RPA experiments failed to detect novel 
splice sites for these RNAs, suggesting they may be degradation products of the larger 
E93 RNAs.  
 
Rationale 
In Chapter IV, I showed that the E931, E932, and E933 alleles are able to execute the 
imaginal patterning functions of E93 normally, but are defective in larval cell death.  
Conversely, the E93Vno alleles are defective in imaginal patterning during metamorphosis, 
but can execute the larval cell death function almost normally.  One explanation for the 
specificity of these two allele types is that they affect alternate products of the locus that 
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execute the two functions.  In this Chapter, I describe my efforts to identify alternate 
products from E93. 
 
Methods  
Pupae were staged by collection of white prepupae.  Total RNA was extracted from 
larvae or pupae using the TRI Reagent (Sigma Cat# T9424).  PolyA mRNA was purified 
using the PolyATract mRNA Isolation System IV (Promega Cat# Z5310). All samples 
were normalized by their O.D. value (measured using a NanoDrop ND-1000 
Spectrophotometer), and stored at -70˚C before use.  
Northern Blots 
 
RNA samples were separated on 1.5% Agarose (ISCBioExpres Cat# E-3120-500) gels in 
2.2 M formaldehyde and 1X MOPS buffer (20mM MOPS pH 7.0, 2mM NaOAc, 1mM 
EDTA pH 8.0), transferred to a Nitrocellulose Transfer Membrane (Micron Separations 
INC. Cat# E04HY00010), fixed on the membrane by 90 seconds of U.V. irradiation, 
incubated with radioactive probes, and exposed to X-ray film to detect signals. For reuse 
with other probes, membranes were stripped in 0.1% SDS or Strip-EZTM RNA (Ambion, 
Cat# 1360-1368).  
 
Probe sequences were amplified by PCR, purified by MinElute Gel Extraction Kit 
(QIAGEN Cat#28604), ligated with the pSTBlue-1 AccepTorTM Vector (Novagen Cat# 
70595-4DFRZ), and transformed into NovaBlue SinglesTM competent Cells (Novagen 
Cat# 70181-4PKG) or Electrocompetent Cells (Lucigen Corporation, Cat# 60052-4). The 
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molecular map of each probe is shown in Fig. V-1. The primers used to generate each 
probe are included in the Appendix. For rp49, DNA probes were labeled with 32P by 
Oligolabeling using random primers (Pharmacia Cat# 27-9250-01). DNA probes were 
also used for the 1st half of pipsq (P1) and the 2nd half of pipsq (P2); these were labeled 
with 32P by PCR (Fig. V-9). All other probes were RNA, and were labeled with 32P by in 
vitro transcription from the SP6/T7 promoter (MAXIscript SP6/T7 kit Ambion Cat# 
1320). Probes were purified on Sephadex G-50 columns pre-equilibrated with STE (0.1M 
NaCl, 10M Tris-Cl, 1mM EDTA pH8.0), and denatured before use.  
 
Densitometry was measured by BIO-RAD Fluor-S MultiImager and normalized by the 
background and rp49 loading control in the same lane with equal area. For example, the 
normalized-Banddensity = (Banddensity - Backgrounddensity) / (rp49density - Backgrounddensity)  
 
2ug total RNA was used for reverse transcription, which was conducted at 44˚C f or 1 
hour, followed by 10 min 92˚C heat inactivation of the reverse transcriptase 
(RETROscriptTM Kit, Ambion Cat#1710). Reaction without reverse transcriptase was 
used as negative control to ensure no contamination from genomic DNA.  
Reverse Transcriptase PCR (RTPCR) 
 
5ul of reverse transcription products were used for the next PCR reaction. Different 
primers were tested to avoid unwanted side products. The final primers used in RTPCR 
are shown in Fig. V-4, sequences are included in Appendix. Different cycle times (20-30 
cycles) were tested to ensure that the amount of product was below the saturation. The 
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optimized thermocycle profile was:  95°C 4min one cycle; 94°C 0.5min, 61°C 25sec, 
72°C 1.5min (1min per kb of target) 30 cycles; 72°C 5min one cycle, 4°C forever.  
 
The cDNA LP library were constructed from pupal stage RNA using the Uni-ZAP XR 
Vector Kit and Uni-ZAP XR Gigapack Cloning Kits. The E93 C-terminal fragment 
(5exoIII) was labeled by Oligolabeling (Pharmacia Cat# 27-9250-01) and used to screen 
the LP library. Positive clones were purified, and the pBluescript phagemid excised using 
the ExAssist Interference-Resistant Helper Phage into the SOLR bacteria strain 
(Stratagene Cat#200253). The pBluescript phagemid clones were stored in glycerol stock 
at -80˚C. The molecular map of identified cDNA clones are shown in Fig. V-9. Their 
sequences are included in the Appendix.  
cDNA screening 
  
RNA probes were labeled by in vitro transcription (MAXIscript SP6/T7 kit, Ambion 
Cat# 1320). RNA samples were hybridized with RNA probes and digested by RNase 
A/RNase T1 Mix (RPA IIITM kit, Ambion Cat# 1415). Samples were separated in 6% 
acrylamide. Signals were detected by X-ray film. 
Ribonuclease Protection Assay (RPA) 
 
Results 
 
Northern blotting 
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Figure V-1: The molecular map of probes used in Northern blots  
The green and red boxes represent LP0 and E93 transcripts respectively. The shaded 
areas represent the predicted ORFs. The dashed lines in E93 represent omitted sequences. 
The relative positions of E93Vnoe47, E93Vnoe31, E93Vnoe18 and E931 are indicated above the 
transcripts. The E93Vnol(3)ry93 is inserted before the 1st exon of E93, and between the 3rd 
and 4th exon of LP0. The grey boxes are the probes used in Northern blots. LP0 US (LP0 
unique start) is specific to LP0 (grey box with green outline). E93 US and AccI fragment 
are specific to E93 (grey boxes with red outline). The other probes come from shared 
common exons of LP0 and E93. The P1 (the 1st half of pipsq) and P2 (the 2nd half of 
pipsq) probes are DNA probes, all the other probes are RNA probes (rp49 DNA probe is 
not included in this picture, because it is from a different gene). 
 
I first examined the expression profile of E93 by Northern blotting. Baehrecke and 
Thummel (1995) detected a 9.5 kb transcript using an AccI fragment from the E93 3' 
UTR as probe.  I confirmed this result and found a similar expression profile: the 9.5 kb 
transcript is expressed at 12hr AP and disappears by 48hr AP in wild-type total RNA 
probed by AccI RNA probe (Fig. V-2).  The same result was obtained when the RNA 
probe from the 5' unique start region of the LP0 transcript (LP0 US) was used (Fig. V-2). 
The lower band visible in the LP0 US blot is probably ribosomal RNA (Fig. V-2). When 
LP0    
E93Vnoe47 E93Vnoe31 E93Vnoe18   E931 
 
 
E93Vnol(3)ry93 
   
 E93   
2 3 4exo 5exo I 5exo II pipsq 5exo III 
E93 ORF MUS  E93 U S LP0 US  AccI fragment 
P1 P2 
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the RNA probes from the 5' start region unique to E93 (E93 US) or the E93 ORF Minus 
the Unique Start (E93 ORF MUS) were used, a heavy smear is detected, probably due to 
the presence of repetitive regions in these probes (Fig. V-2). 
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Figure V-2: The expression profile of wild type Total RNA probed by AccI, LP0 US, 
E93 US, and E93 ORF MUS 
Total RNA of wild-type staged pupae (0-48hr AP) was extracted and 40ug total RNA 
was loaded per lane. RNA probes of AccI, LP0 US, E93 US, and E93 ORF MUS 
fragments were used to probe the blots. 
  
The P-element insertion in the allele E93Vnol(3)ry93 lies 5' to the E93 transcript, and within 
an intron of the LP0 transcript (see Fig. V-1, Fig. IV-1).  This allele is defective in the 
imaginal patterning function of E93 but does not appear to affect the cell death function.  
We wondered whether this allele might specifically affect expression of the LP0 
transcript. The P-element in the E93Vnol(3)ry93 insertion carries rosy+ (ry+) as a marker.  
The ry+ fragment in this element includes a portion of an adjacent gene, l(3)S12.  When 
inserted within an intron, this fragment of l(3)S12 can act as a splicing acceptor and 
transcriptional terminator (Horowitz and Berg 1995). Thus, one might expect the l(3)S12 
insertion to cause truncation of the LP0 transcript, but to have no effect on the E93 RNA.  
Such a finding would support the model that the LP0 transcript is responsible for the 
imaginal patterning functions of E93, while the E93 transcript is responsible for its cell 
death functions. Surprisingly, when LP0 US was used as an RNA probe, E93Vnol(3)ry93 
homozygotes showed a 9.5kb band, as in wild type, indicating that termination does not 
always occur within the insertion. Bands of 5kb and >9.5 kb are also present (Fig. V-3). 
To determine whether any of these bands contained l(3)S12 sequences, the blots were 
reprobed with l(3)S12 RNA probe.  This probe detects the 9.5 kb and >9.5 kb bands plus 
The LP0 and E93 transcripts show no tissue specific distribution 
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a new band at ~6kb, but did not detect the 5kb band, whose origin remains unexplained 
(Fig. V-3). None of these bands are endogenous l(3)S12 transcripts, as these are only 
0.7kb in size.  
 
Figure V-3: The expression profile of wild type and E93Vnol(3)ry93 mutant  
Total RNA of E93Vnol(3)ry93 and wild-type staged pupae (0-45hr AP) was probed by LP0 
US and l(3)S12 RNA probes. P/P represents E93Vnol(3)ry93 homozygotes; P/+ represents 
E93Vnol(3)ry93 heterozygotes; +/+ represents wild-type.  40ug total RNA per lane.  
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Figure V-4: The molecular map of primers used in RT PCR  
The LP0 and E93 transcripts are as described in Fig. V-1. The arrows below the LP0 and 
E93 cDNA are the primers used in RTPCR. The sizes of expected RTPCR products are 
indicated in the parentheses.  
 
To determine whether the E93Vnol(3)ry93 P-element sequences are ever correctly spliced out 
of the mature LP0 transcript, we performed RTPCR to amplify transcript sequences 
spanning the insertion site.  As indicated in Fig. V-4, a primer complementary to the end 
of the third common exon of E93 and LP0 was used to prime reverse transcription (the 
black arrow labelled #1 in Fig. V-4; the sequences of this and all other primers are 
included in the Appendix).  PCR was then carried out using a 5' primer specific for the 
LP0 transcript (the green arrow #3) and an internal backward primer (the black #2 arrow).  
PCR was also carried out using a 5' primer specific for the E93 transcript (the red arrow 
#3) and the internal backward primer (black arrow #2). The PCR products for LP0 and 
E93 are distinguishable by size (985bp for LP0, 916bp for E93). We were surprised to 
find that E93Vnol(3)ry93 mutant homozygotes produce normal sized RTPCR products for 
LP0 (Fig. V-5).  These products were sequenced and no differences were found relative 
to the same PCR products from wild type.  This observation indicates that the P and Doc 
elements do not cause strong transcriptional termination and are correctly excised from 
LP0    
E93Vnoe47 E93Vnoe31 E93Vnoe18   E931 
 
 
E93Vnol(3)ry93 
   
 E93           (     916 bp     ) 
#3                                   #2 #1 
         (                  985 bp                     ) 
#3                                                          #2 #1 
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the LP0 transcript in the E93Vnol(3)ry93 mutant.  I also used RTPCR to examine the 
expression profiles of LP0 and E93.  These experiments show that in wild type LP0 is 
weakly expressed at 0hr AP, increasing gradually from 9-45hr AP, whereas E93 is 
expressed robustly all the way through the period 0-45hr AP (Fig. V-5, whole animal 
+/+).  In E93Vnol(3)ry93 homozygotes, LP0 expression is weak in 0-18hr AP, and increases 
from 27-45hr AP; E93 is present in all stages (Fig. V-5, whole animal P/P).  Compared to 
wild type, E93Vnol(3)ry93 homozygotes show a delay in expression of LP0 and may show an 
overall reduction in expression of LP0 and E93. I also used RTPCR to examine the tissue 
specificity of LP0 and E93 expression (Fig. V-5).  The results indicate that both LP0 and 
E93 are expressed in both imaginal discs and salivary glands.  Taken together, my results 
argue against the hypothesis that the LP0 transcript is responsible for the imaginal 
patterning function of E93 or that the E93 transcript functions specifically to drive larval 
cell death. 
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Figure V-5: RTPCR of wild type and E93Vnol(3)ry93 mutant.  
P/P represents E93Vnol(3)ry93 homozygotes; P/+ represents E93Vnol(3)ry93 heterozygotes; +/+ 
represents wild type. 
 
To look for additional alternate transcripts, I returned to Northern blotting.  Instead of 
using the entire coding region as probe, which produces a heavy smear, we dissected the 
coding region into smaller fragments and used these as probes on blots of total and 
polyA+ RNA from wild type.  Two RNA probes from the C-terminal region of the 
coding sequence (the Pipsq probe and 5exoIII probe see Fig. V-1) provided striking 
results.  These probes detected three strong bands of 1.7kb, 1.4kb and 0.6kb in RNA from 
pupae at 9hr AP (Fig. V-6).  These bands are detectable in total RNA, but are strongly 
enriched in polyA+ RNA (Fig. V-6). The 5exoI and LP0 US probes appear to detect very 
weakly these same bands.  Other fragments from the ORF detected smeary patterns, with 
bands of 2.5kb and 4kb visible in polyA+ RNA blots (Fig. V-6).  
Three small transcripts detected by Northern blotting 
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Figure V-6: The expression profile of wild type Total RNA and PolyA+ RNA probed 
by Pipsq, 5exoIII, LP0 US, E93 5exo I, E93 US, E93 234exo, and E93 5exoII. 
L represents 3rd instar larvae; 0, 9, 18 represent 0-18hr AP. 5ug Total RNA or 0.5ug 
PolyA+ RNA per lane.  
 
I then used the pipsq probe to check the expression of these small transcripts throughout 
the period from late third instar larva to 48hr AP in 3 hr intervals.  In this period, these 
RNAs appear only around 9 hr AP (Fig. V-7).  Northern blotting of samples taken every 
half hour from 6.5 hr to 11 hr AP shows that the small transcripts are induced at 7AP and 
disappear by 11AP (Fig. V-7). 
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Figure V-7: The expression profile of three small transcripts in WT animal 
L represents larvae, numbers above the lanes represent 0-48hr AP, 5ug Total RNA per 
lane 
 
One or more of the 1.7kb, 1.4kb and 0.6kb transcripts might be responsible for the cell 
death functions of E93.  There are four reasons to suspect such a role:  first, these RNAs 
include the C-terminal region of E93 where the E931 allele is located. Second, these 
RNAs do not appear to contain most sequences from the N-terminal portion of E93, 
where the E93Vno alleles are located.  Third, these RNAs are produced just prior to 
salivary gland cell death.  Fourth, the transcripts detected by the C-terminal probes are 
below the size cutoff of most cDNA libraries, perhaps accounting for why they have not 
been detected previously.   
 
If the small RNAs are responsible for the cell death function of E93, one might expect 
their levels or size to be affected by alleles that are defective in this function.  As a 
control, I first used 5exoIII to probe Northern blots of RNA from wild-type hemizygotes 
and wild-type homozygotes.  All three bands showed a reduction in intensity by about 
half in hemizygotes (Fig. V-8 A), suggesting that the small RNAs are encoded by the E93 
locus and are not being detected by cross hybridization.  I then examined E931, E932, and 
E933 mutant hemizygotes.  The three small RNAs are reduced in these three genotypes 
relative to wild type, but no more than expected from the hemizygosity of the locus (Fig. 
V-8 B). The E93Vnoe31 and E93Vnoe47mutants also showed small reduction in upper and 
middle bands (Fig. V-8 C, D), but E 93Vnoe18 and E93VnoPry93 showed similar intensity 
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compared with wild type (Fig. V-8 E, F).   The Tp(3;3)Vno mutants showed a smeary 
pattern (Fig. V-8 G). 
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Figure V-8: The reduction of small RNA transcripts in E931/2/3 mutants, E93Vno 
mutants, and wild-type hemizygotes 
rp49, a ribosomal protein gene, was used as loading control (prepared as DNA probe by 
Oligolabeling using random primers). The right panel shows the densitometry of the three 
small bands after normalization. Wild type and the mutants are color coded as indicated 
above the lanes. 5ug Total RNA or 0.5ug PolyA+ RNA per lane. 
 
I also used sub-fragments of the E93 pipsq probe to see whether these bands are specific 
to a smaller region. The 1st half of pipsq DNA probe (P1 in Fig. V-1) did not detect any 
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signal after 98hr exposure (Fig. V-9 A). The 2nd half of pipsq DNA probe (P2 in Fig. V-1) 
detected the two smaller bands (Fig. V-9 B). 
 
 
Figure V-9:  Authenticity test of the three small transcripts by subfragments of 
pipsq probe 
A: Wild-type 9hr AP PolyA+ RNA (0.5ug) probed by the 1st half of pipsq DNA probe; B: 
Wild-type 9hr AP PolyA+ RNA (0.5ug) probed by the 2nd half of pipsq DNA probe; C & 
D: The blots used in A & B were stripped and reprobed by pipsq RNA probe to confirm 
the RNA sample is still intact. 
 
To determine whether RNAs were transcribed from the sense strand of pipsq and 5exoIII, 
I used sense strand RNA probes from these regions to probe Northern blots.  The sense 
strand of 5exoIII did detect a small RNA after 4hr exposure (Fig. V-10 B). However, the 
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sense strand of pipsq did not detect any obvious band, even after 20hr exposure (Fig. V-
10 C).  
 
Figure V-10: Authenticity tests of the three small transcripts by sense strand RNA 
probes 
A: The wild-type 9hr AP Total RNA (5ug), PolyA- RNA (5ug), and PolyA+ RNA (0.5ug) 
probed by pipsq RNA probe; B: The blot used in A was stripped and reprobed by 5exoIII 
sense strand RNA probe; C: the blot used in A and B was stripped and reprobed by pipsq 
sense strand RNA probe. 
 
The three small RNAs that appear at 9 hr AP suggest that novel splice sites may be 
present in the 3’ portion of the E93 coding sequence.  To search for such sites, I used the 
Pipsq and 5exoIII probes in Ribonuclease Protection Assays (RPA).  When I used the 
Attempt to identify the three small transcripts by RPA 
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pipsq probe, I saw two small protection bands in Total and PolyA- RNA lanes, but not in 
PolyA+ RNA (Fig. V-11 lane 3-5).  Since Northern blotting indicates that the three small 
transcripts are enriched in PolyA+ RNA (see above), it seems unlikely that the protected 
bands represent these transcripts. No specific protection was detected for the 5exoIII 
probe (Fig. V-11 lane C-E). A probe covering the boundary of E93 5exon (which protects 
the first 240bp of E93 5exon) was used as a positive control to ensure the RPA assay was 
working properly (data not shown). 
 
 
Figure V-11: RPA assay 
The blot on the left was probed by Pipsq, the blot on the right by 5exoIII; Lane 1 and A 
are RNA ladders; Lane 2 is Yeast RNA (2ug) plus Pipsq probe (560bp expected); Lane 3 
is Pipsq protected by Fly 9 hr AP Total RNA (25ug) (445bp expected); Lane 4 is Pipsq 
protected by Fly 9 hr AP PolyA- RNA (30ug); Lane 5 is Pipsq protected by Fly 9 hr AP 
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PolyA+ RNA (1.8ug);  Lane B is the 5exoIII probe plus Yeast RNA (2ug) (904bp 
expected); Lane C is 5exoIII protected by Fly 9 hr AP Total RNA (20ug) (802bp 
expected); Lane D is 5exoIII protected by Fly 9 hr AP PolyA- RNA (20ug); Lane E is 
5exoIII protected by Fly 9 hr AP PolyA+ RNA (1ug).  The origin of the two small bands 
(~150 bp and ~350 bp) in lanes 3&4 is not known, but is unlikely to be due to the small 
RNAs detected by Northern blotting. 
 
As a second approach to identifying alternate transcripts, I screened a fly cDNA library 
constructed from pupal stage RNA (the LP library) using a C-terminal fragment (5exoIII) 
as probe.  I recovered 6 clones, but none are alternatively spliced and all are at least 2kb 
long (Fig. V-12, white boxes, detailed sequence information is available in Appendix).  
However, I did make two new discoveries. First, I found two new 5’ exons in clone 2.  In 
genomic DNA, these exons extend 3.2kb upstream of the E93 transcript and 1.7kb 
upstream of the E93Vnol(3)ry93 insertion. Second, all six clones end at the same place, 
300bp downstream of the ORF, suggesting that most E93 transcripts do not contain the 
large 3' UTR present in the 9.5kb E93 transcripts.  
cDNA screening for additional alternate transcripts 
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Figure V-12: The molecular map 6 clones discovered from cDNA screening.  
The LP0 and E93 transcripts are as described in Fig. V-1. The white boxes are the 6 
clones identified from cDNA screening. Clone 2 has two novel exons presented by grey 
boxes.  
 
Discussion 
In this chapter, I search for alternate products of E93 that might be responsible for its 
larval cell death and imaginal patterning functions. Northern blotting confirmed the 9.5kb 
E93 transcript described by Baehrecke and Thummel (1995) and provided a profile for its 
expression.  Probes specific for the LP0 transcript also detect RNAs of 9.5 kb.  The LP0 
transcript appeared initially to be a good candidate for executing the imaginal patterning 
functions of E93.  E93Vnol(3)ry93 is a Vno-type allele associated with the insertion of a P 
element and two Doc elements within the third intron of the LP0 transcript, just upstream 
of the E93 transcript.  The P-element in the E93Vnol(3)ry93 mutant carries a fragment of 
l(3)S12 that in other contexts causes termination of transcription (Horowitz and Berg 
1995).  Therefore, an attractive model was that premature termination of the LP0 
transcript in this allele was responsible for its effects on imaginal patterning.  However, 
to my surprise, I found that the LP0 transcript is not eliminated in the E93Vnol(3)ry93 mutant, 
indicating that transcriptional termination by the l(3)S12 sequence does not occur in this 
context, or occurs with low efficiency.  In addition, RTPCR experiments demonstrated 
that the P and Doc sequences are correctly excised from the E93 primary transcript.  
RTPCR experiments also demonstrated that the LP0 and E93 transcripts are expressed in 
 95 
both larval and imaginal tissues, arguing against the possibility that either specifically 
executes the larval cell death or imaginal patterning functions of E93. 
 
Northern blots also demonstrated the existence of three small transcripts in PolyA+ RNA 
(Fig. V-6, Fig. V-7).  These are good candidates for the larval cell death function of E93, 
as they appear just prior to salivary gland death and are detected by the 3' portion of the 
coding sequence, near where the E931 allele is located.  Attempts to identify these RNAs 
by RPA were inconclusive; no novel splice sites were detected using the pipsq and 
5exoIII regions of the E93 coding sequence as probes (Fig. V-10).  The small RNAs may 
be degradation products of E93 produced during apoptosis and their functions, if any, 
may be unrelated to cell death. 
 
Besides the three small RNAs, transcripts of 2.5kb and 4kb were detected by many 
probes (E93US, 234exo, 5exoI, 5exoII, and 5exoIII, Fig. V-6). Although these bands are 
variable in intensity, they are very robust compared with the original 9kb band detected 
by the 3' AccI probe, suggesting that some E93 transcripts may not contain the long 3’ 
UTR region. In an attempt to identify these potential alternate transcripts, I screened for 
additional cDNAs using 3' coding sequences as probe.  Of six cDNAs identified, one 
(clone2) has a novel 5' exon, but it contains the same coding region as E93.  
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Chapter VI : Future directions 
 
The study of the role of E93 in imaginal patterning during metamorphosis promises to 
provide important insights into how stage-specificity is achieved during development.   
Here are some questions I think future work should be directed toward answering: 
 
A. How does E93 regulate Dll expression?  I have shown that Dll lies downstream of E93 
in the bract pathway, but we do not know whether E93 regulates Dll through direct 
binding or through other genes and/or cofactors.  Identification of the Dll bract enhancer 
and study of its interaction with E93 and Pnt is a high priority, and could serve as a 
model for understanding how E93 provides temporal specificity during metamorphosis. 
 
B. Where in the bract pathway does ecdysone signaling act?  So far, clones that are 
knocked down for the ecdysone receptor have failed to show any effect on E93 
expression in bract cells.  Clones having a more severe knockdown of receptor activity, 
either usp mutant clones or EcR RNAi clones, need to be generated to test whether 
ecdysone signaling is required for E93 expression in bract cells and other imaginal tissues.  
If ecdysone does not control imaginal expression of E93, then it will become a key to 
determine whether EcR interacts directly with the Dll bract enhancer and/or with Pnt.  
 
C. Are distinct domains of E93 involved in executing the imaginal patterning and larval 
cell death functions of E93?  I have generated stocks which should allow testing the 
abilities of portions of E93 to rescue the cell death and imaginal patterning functions of 
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E93.  These experiments could provide an explanation for the different phenotypes of the 
Vno and cell-death alleles of E93.  
 
D. What is the relationship of E93 and pnt during bract formation?  My data suggest that 
pnt activates E93 expression early in metamorphosis, but that these genes engage in 
mutual repression at later stages.  The changing roles of these genes should be explored 
further by generating ectopic expression and loss of function clones of E93 and pnt.  
 
E. What is the nature of E932 and E933 alleles?  My results suggest that E932 and E933 
may be mutations in larval-cell specific regulatory sequences of E93.  To test this idea, 
the changes present in the E932/3 alleles should be determined by a combination of 
genetic mapping and DNA sequence analysis. 
 
F. Are alternate E93 transcripts responsible for the larval cell death and imaginal 
patterning functions?  My work did not resolve the role of the small E93 RNAs detected 
by 3' probes.  Further work should be conducted to determine their structure and 
expression patterns. 
 
G. What is the role of E93 in patterning other tissues?  Much work remains to determine 
the role of E93 in patterning tissues other than bracts.  Because so much is known about 
eye development, the role of E93 in patterning the 2nd and 3rd pigment cells is likely 
tractable; a first approach here would be to use existing lacZ markers for specific cell 
types to determine which cells in the eye express E93.  The role of E93 in wing vein 
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formation is likely also tractable, as the wing vein enhancer of dpp has been defined 
(Sotillos and de Celis 2006).  E93 is known to be expressed in the heart during 
remodeling (Zeitouni et al. 2007), but its role here is unknown.  As a first approach, heart 
remodeling should be examined in the E93Vno mutants to determine if abnormalities are 
present.  The different cases of neuronal remodeling should also be examined in E93Vno 
mutants.   
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Appendix 
Stocks used in the experiments 
 
hs-rasV12/CyO   perimon 
w118; Df(3R) Exel 6188 / TM6B (E93 Df stock) 
Tp(3;3)Vno / TM6B 
w/+; +; E93Vnol(3)ry93 / TM6B  BL# 10616 
UAS-pnt.P1: w[1118]; P{w[+mC] pnt[P1.UAS]=UAS-pnt.P1}3 (BL# 869) 
Aos-lacZ: P{ry[+t7.2]=PZ}argos[05845] CG33158[05845] ry[506]/TM3, ry[RK] Sb[1] Ser[1] 
(BL# 11674) 
 
y w FLP122; FRT82B CD2 y+ M(3)W Bsb / TM6B   
y w FLP122; FRT82 Ubi-GFP83/TM6B  
FRT82B sr es E93Vnoe47 ca/TM6B  
FRT82 roe pp cu sr pntΔ88/TM6B  
FRT82B cu E931/2/3 ca / TM6B ♂ 
 
 106 
y w FLP12; Act>y+>Gal4 UAS-GFP  
y w FLP12; Act>y+>Gal4 UAS-GFP; tub-Gal80ts E93Df/TM6B  
UAS-EcR-RNAi: w[1118]; P{w[+mC]=UAS-EcR-RNAi}97 on 3rd (BL#9326) 
UAS-E93-ORF; E93Vnoe47/TM6B  
 
 
 
E93 antigen I-III sequence and primers used for amplification 
 
(543..782 Gly47-Ala126) 
E93 antigen-I  
E93 antigen-I (F)543-558: CCGGAATTCggttccgaggacgagc 
E93 antigen-I (B)782-768: CGCAAGCTTGggccgacggtctcca  
 
GGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGC
CAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAA
CACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACA
TCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCAC
CACCGCCAGAACCCATCGATTGGAGACCGTCGGCC 
 
(1257..1604 Ala285-Ala400) 
E93 antigen-II 
E93 antigen-II (F)1257-1272: CCGGAATTCgcactcaaagatacac 
E93 antigen-II (B)1604-1590: CGCAAGCTTGcgcattgctgtccac 
 
GCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCA
GCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGC
CTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCT
GAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATC
GGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAG
ATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGAC
TCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCG 
 
(3399..3779 Asn999-His1125) 
E93 Antigen-III  
E93 antigen-III (F)3399-3414: CCGGAATTCaaccatcggaacaatg 
E93 antigen-III (B)3779-3765: CGCAAGCTTGgtgactgctgctgct 
 
AACCATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGA
GCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGG
AGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCA
GCCACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCG
GCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGA
GCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAA
GAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGG
CGGCAGCAGCAGCAGCAGTCAC 
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Sequence of E93 UAS constructs 
 
Note: Boxed capital letters are predicated ORF of each construct. Small letters are 
flanking sequences that inserted into the vector with the predicated ORF.   
 
Primers: 
UAS-ORF 
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424)): 
caacatgcacatcagcagctatga 
#13 E93-clone2-end (4007-4026)(4599-4618, clone2 numbering):tttgtatggtactatcaaaa 
 
Sequence: 
caac 
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
 108 
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
 109 
CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCA
TCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTA
AAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGC
CTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCAC
ATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGC
GGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGC
CGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGC
GGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGC
AGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACAT
CACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGA
TCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaagccacgttttttgatagtaccatacaaa 
 
Primers: 
UAS-clone2 
#12 Clone_2(f) (1-20): gca gaa ata caa cgc atc cg  
#11 E93 ORF downstream (3988-3969) (4580-4561, clone2 numbering): 
gttccccctccctccgccta 
 
Sequence: 
 110 
gcagaaatacaacgcatccgatatgcaacggaacgcattttcggacgcggcccgagtcgttccgaggtgtagcgtccgattccg
attcagattcagattccgacgatcgcgtatatcaatcatattaaacaaaaacaacaactgcaacaacaacggctacacttttgttagt
aaatttctgttgaattaaaatacgaaacaaaacatataaaaaagtgcaatccaaaaaaaacaaatattaacgttaaacgaactataa
agcaaaataattaaaaaagtagccattacttttgaattgttttcaaatgcaaaaaagaaaaaggttcgtaagcaacaaaaaaaaagt
taaatgctaaagcattttgataatgcaacatatcaaagagccagaatttaaacacagcaaaaaataaataaaataattaatatacaa
acacgcggggcaactgtcaaaaaatctacaacaacacaaagtgcaactttcaacaacaacaaaataagtgcagcagtacaaca
acaaaaagcattacacaattgaacaaacaacatacaaaaaaaaaatattgccaccaaataaaaaaaaacccgaaagaaaattcg
cgcttcattttcacgcgctgcatataatttactctgtgctccacatatatatatatatatatatataataaataaaaaccaaccaatagcc
caaaaaaaaagaaatgaaaagtccgcatcaacaataaaaatctgcctgcatttttgccttttgtgtgagctgcccaccagaacgag
agaagcacttttattgtatataaaaattatatacatcgccgggaggagctgcagcaacccactccaagccagggttgccacgtcct
gagctgctgtaagctctccgcagcagctgcagcagcatcagcatcgcagcagcatcagcagcagcgcagcaaccgccgcag
catcaatttggcttttgggcagagataatttaagacaaatatatgtgatgct  
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
 111 
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
 112 
CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCA
TCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTA
AAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGC
CTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCAC
ATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGC
GGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGC
CGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGC
GGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGC
AGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACAT
CACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGA
TCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaac 
 
Primers: 
UAS-E931Nterm 
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ): 
caacatgcacatcagcagctatga 
#3.3 stop-CD1 (f): catcggctgctcctagggggtcttcttcac 
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc 
#2.3 CD1-stop(b): gtgaagaagaccccctaggagcagccgatg 
 113 
 
Sequence: 
caac 
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
 114 
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGG
AACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGT
GGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGG
TAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGT
CACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCG
GCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGAC
CACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGC
GGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAA
CGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGC
CGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTT
CAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGC
CTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCA
 115 
GGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCA
GCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACG
CCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa 
 
Primers: 
UAS-E93Vnoe47Nterm 
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ): 
caacatgcacatcagcagctatga 
#6.2 stop-e47(f): gctgctcctactcatggtgctggctagccg 
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc 
#5.3 e47-stop(b): gcaccatgagtaggagcagccgatggccgc 
 
Sequence: 
caac  
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
 116 
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGTAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa 
 
Primers: 
UAS-E93Vnoe47Cterm 
caac-ATG(after e47 at 1515): CAACatgaaacaccatgacc 
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering): ttaatttggtgttccccctc 
 
Sequence: 
caac 
ATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGAC
TCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGT
ATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGA
GCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAAT
GGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCA
TCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGG
GATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATC
AAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTA
AATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGC
TGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGC
AGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGAC
TCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATA
CTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGT
CGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAG
CCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGG
CAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCC
 117 
CAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCAT
ACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGG
CCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGG
CGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATC
ATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCC
AACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCT
GAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTA
TCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGG
GCAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCA
GCAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATT
TGGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATG
GCCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATT
CCGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAA
ACCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCA
AGTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCA
 118 
CGTCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACC
AGGCGGATCAGTTATAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa 
 
Primers: 
UAS-Δpipsq 
E93 CAAC-ORF start primer (E93_CAAC-ORF(f) (CAAC-405-424) ): 
caacatgcacatcagcagctatga 
#8.5 flank-pipsq(f): ctggggccagaacatctgttgctgctgttg 
E93 ORF triple stops (3979-3998)(4571-4591, clone2 numbering):ttaatttggtgttccccctc 
#7.5 flank-pipsq(b): caacagcagcaacagatgttctggccccag 
 
 
Sequence: 
caac  
ATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAATGTA
TGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCACTT
GAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAGCC
ATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAACCA
CTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAGCT
ATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCACGT
ACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCATCG
ATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTAAC
GGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTAGT
AGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTCGA
GTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAATA
GCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACAC
CAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCCA
GCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGCA
ATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAGC
AGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
 119 
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGG
ATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGC
CAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTG
CTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATG
AAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGG
TGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAAC
AGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACC
ATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCG
GCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCG
AACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCG
GTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCA
CCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCA
CAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCG
CCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTT
TGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCA
GCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGT
TAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAG
CCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCG
GAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGAC
CCACCAGCAACAGCAGCAACAGATGTTCTGGCCCCAGACGAACGCCACGAA
TGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAG
 120 
GCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAAC
GTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGC
AGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCAC
GGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCC
CCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTCGAG
TGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGC
AGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGA
GGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCACAA
CAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAA
TGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGA
TGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAAT
GATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATC
GGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACTG
CACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAG
TTATAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaa 
 
cggttcgcttcggtcccggccccgctgatttggatttggattcggattctcggtttctcggtttctcggcttcacgcttcctcggattct
cggtttctcggatacttggctactccgatagtgggatattctcgccagactcggcttctctgcgagattctccattctcctcactgccc
agacgggcgattcttgtgcccgaccgatttgggttcggatcgaaggcggcgttcgctgctgcagcgtttgccggcgtcgctgcct
gcgctcttgcgtattagtaacgtcgttgacatgccaggccactaaaaacgaaaaaaaaaaataaaaaagtaaaaagagctgaaa
atgcaaaagtgctgtgacaaccacaaataaatgatagaaggaaaaaagtttaatacattaaaaacaaataccacaaacaaagtca
acgttttcatcgtactgcaaaaaaaccacaaattttttacatatttacattaatgagcttgtaaatattgggacgcattgccacgaaaa
gtacagttgcgatctaacaatatcgccaatatatcctcaaaaagaaagct 
UAS-LP0 in pUAST (made by Dianne Duncan) 
ATGGCCGATTGTTCATATGTGAGATGTCAGCAAGAGCGTCGGCTCATCAAAA
AGAAGCTATTGAAATGGTCCACAGATATGCTGCATATTGTGGCCCTAGAACG
CGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAA
CTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCG
 121 
GTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCC
AGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAAC
ACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACAT
CACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCACC
ACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTT
AACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAG
CAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGA
CAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGC
AGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCA
AGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCT
ACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGG
CCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCG
CTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTA
ACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAG
ATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATC
GCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACG
CCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCC
CTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGC
ACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCA
TGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGA
TGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGA
GTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGC
AGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACAT
CCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGC
TGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCA
ATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGC
TGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTC
CGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAA
CAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAA
 122 
CATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGA
ACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCC
GTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGA
CTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCA
GCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCA
GCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTA
CTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATG
ATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGT
CTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCT
CGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAAC
GGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCAT
TCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGG
AGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATG
ACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGT
CGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTA
CAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCC
GCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGAC
AAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAG
AACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCG
GCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCAC
AGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGAACGCCACGAA
TGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAG
GCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAAC
GTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGC
AGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCAC
GGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCC
CCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTCGAG
TGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGC
AGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGA
 123 
GGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCACAA
CAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAA
TGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGA
TGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAAT
GATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATC
GGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACTG
CACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAG
TTA 
taggagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggag
ggggaacaccaaattaagccacgttttttgatagtaccatacaaatcactaaatagaattatatatatatatatatatatatatatacata
tataataatttatgccagccagctgaccgatgtgcgtggtaaatgtgcgctagctcttagttaaatgtgtaatcaactgcatagggga
aaaacaaaaccacaggaaatcataaacaacaacaaacaaacaaaaaaaaaaaaaaaaaa 
 
The pUAST sequence preceding the ORF should be “agatctt” followed by the first 
“ATG”. The predicated ORF should start from the first ATG in grey shading, like this: 
agatcttATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAA
TGTATG……  
UAS-E93 in pUAST (made by Baehrecke) 
 
However, the red “tAT” mutated into “G” at the beginning of ORF, so the predicated 
ORF may start from the next in frame ATG in grey shading, like this: 
agatctGGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAAT
GTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCC
ACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACG
AGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCA
ACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCC
AGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATC
ACGTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCC
ATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGC
TAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCAC
 124 
TAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAAC
TCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACA
ATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAA
CACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGAC
CCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGC
GCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAAC
AGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCT
CAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCC
CAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCG
ATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGG
GAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGG
TGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGC
GCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCA
GGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGA
AGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCA
CAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCG
AGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCA
ATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGT
CCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTG
GATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACA
GTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGA
GAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAA
CACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCT
ACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGA
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCG
CATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAA
 125 
CAGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAAT
ATCCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGA
AATGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACA
AGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACG
GTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACC
TGACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCA
AGGGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTT
TGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAG
CGGGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGA
ACGTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTC
GTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCG
GGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATC
AGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGC
CCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTT
CAGCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGG
ACTTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCA
CGGCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCAT
CATCAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAA
TGGCAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGG
ACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACC
AACCATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGA
GCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGG
AGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCA
GCCACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCG
GCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGA
GCAGCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGA
AGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATG
GCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCG
 126 
GACATCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGC
CCAGATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAG 
gagcagccgatggccgcgaatccagcgttcgcctggccaccgctggccgcccactactacagcttctaggcggagggaggg
ggaacaccaaattaagccacgttttttgatagtaccatacaaatcactaaatagaattatatatatatatatatatatatatatacatatat
aataatttatgccagccagctgaccgatgtgcgtggtaaatgtgcgctagctcttagttaaatgtgtaatcaactgcataggggaaa
aacaaaaccacaggaaatcataaacaacaacaaacaaacaaaaaaaacaaaaataacaagaaccgcaagcaaagaaacata
catttgtgccccggagtgtacgatgtatatttttgtttcgttttgacaatcgacaaataggcattctcttgtacaaactttcttaaaagcta
acaacaaaacaaatctaaaaccttaagaccaaaaaaaacaaaaaatgaaaaaaaa 
 
 
Probes used in Northern and RPA 
 
Forward primer (17792211-31) ACAAAATAAG TGCAGCAGTA C 
E93 unique start (E18set3 clone1.4 pSTBlue1) 
Backward primer (17792840-20) CTCGTTAATT ATTTATGACT C 
 
Flanking intron (101) 
ACAAAATAA GTGCAGCAGT ACAACAACAA AAAGCATTAC ACAATTGAAC 
AAACAACATACAAAAAAAAA ATATTGCCAC CAAATAAAAA AAAACCCGAA 
AG  
 
E93 exone aaaattcgcg……tatgaaatat(1-429) 
AAAATTCGCGCTTCATTTTCACGCGCTGCATATAATTTACTCTGTGCTCCACA
TATATATATATATATATATATAATAAATAAAAACCAACCAATAGCCCAAAAA
AAAAGAAATGAAAAGTCCGCATCAACAATAAAAATCTGCCTGCATTTTTGCC
TTTTGTGTGAGCTGCCCACCAGAACGAGAGAAGCACTTTTATTGTATATAAAA
ATTATATACAT
 
CGCCGGGAGGAGCTGCAGCAACCCACTCCAAGCCAGGGTTG
CCACGTCCTGAGCTGCTGTAAGCTCTCCGCAGCAGCTGCAGCAGCATCAGCA
TCGCAGCAGCATCAGCAGCAGCGCAGCAACCGCCGCAGCATCAATTTGGCTT
TTGGGCAGAGATAATTTAAGACAAATATATGTGATGCTATGCACATCAGCAG
CTATGAAATAT 
Flanking intron (99) 
GTACGTATGCCAAATTGCTTTTTTTTTCAAATAATCGCAAATAAACTAAAAAT
ATATTTAATGATTAATTGTAATTAAT GAGTCATAAATAATTAACGA  
 
CGGTTCGCTTCGGTCCCGGCCCCGCTGATTTGGATTTGGATTCGGATTCT 
LP0 US (LP08695 unique F made by Dianne) 
CGGTTTCTCGGTTTCTCGGCTTCACGCTTCCTCGGATTCTCGGTTTCTCG 
GATACTTGGCTACTCCGATAGTGGGATATTCTCGCCAGACTCGGCTTCTC 
TGCGAGATTCTCCATTCTCCTCACTGCCCAGACGGGCGATTCTTGTGCCC 
 127 
GACCGATTTGGGTTCGGATCGAAGGCGGCGTTCGCTGCTGCAGCGTTTGC 
CGGCGTCGCTGCCTGCGCTCTTGCGTATTAGTAACGTCGTTGACATGCCA 
GGCCACTAAAAACGAAAAAAAAAAATAAAAAAGTAAAAAGAGCTGAAAAT 
GCAAAAGTGCTGTGACAACCACAAATAAATGATAGAAGGAAAAAAGTTTA 
ATACATTAAAAACAAATACCACAAACAAAGTCAACGTTTTCATCGTACTG 
CAAAAAAACCACAAATTTTTTACATATTTACATTAATGAGCTTGTAAATA 
TTGGGACGCATTGCCACGAAAAGTACAGTTGCGATCTAACAATATCGCCA 
ATATATCCTCAAAAAGAAAGCTATGGCCGATTGTTCATATGTGAGATGTC 
AGCAAGAGCGTCGGCTCATCAAAAAGAAGCTATTGAAATGGTCCACAGAT 
ATGCTGCATATTGTG 
 
 
E93 ORF MUS (E93 ORF minus unique start) 
CCCTAGAACG……GGCGGATCAG (430-3896=>3467) 
CCCTAGAACGCGTTGCTGAA E93NUSI(F) 
AAGTGGACCAGGCGGATCAG >> CTGATCCGCCTGGTCCACTT E93NUSII(B) 
CCCTAGAACGCGTTGCTGAA
TTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGA
CTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGA
TCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTA
GTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGC
ACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGC
AAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCT
GTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGA
GCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGC
TAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATG
AAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCC
AACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATC
CGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCA
CAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGG
GCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCC
ATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGAT
TGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAG
GGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATC
TGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCTGCA
GAATGTATGGGTCGCAGGCAATGGAAACATTA
TCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATA
GCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAG
GAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTG
GAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAAC
AACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTA
CACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAA
CTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGG
CCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCA
TCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGC
AGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATT
GCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCC 
 128 
ACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCAGCA
GCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCG
GAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGA
AGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGC
GAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCT
CCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGG
CGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAG
CACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTGAGCG
CCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTATCGCA
ACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGAGGTG
AAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCACGCT
GGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAGAGCC
CAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAG
CTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCC
TCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAG
CAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGG
TCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGAACGCC
ACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCGGAATC
CCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATGGTGGA
GAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAGGGCAA
TGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGGCATGG
GCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGAAGAAG
ACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCACCTGTTC
GAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGCAACTA
TGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGCAGCGA
TGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTGGCGCAC
AACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGCCAGACC
AATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCCGAAACG
GATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAACCACAAA
ATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGTGCGAAT
CGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTCCATACT
GCACGAGAAGCTGGCCCAGATCAAGGCCGAGC
C
GGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTC
AGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGC
AATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAG
GTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAG
AAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAG 
 
AAGTGGACCAGGCGGATCA
G 
E93 ORF MUSII (E93 ORF minus unique start II) 
CAGCAGCAGC……GGCGGATCAG (2171-3896=>1726) 
CAGCAGCAGCAGCCTGTCGC  E93NUSII(F) 
AAGTGGACCAGGCGGATCAG>> CTGATCCGCCTGGTCCACTT  E93NUSII(B) 
CAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCG
CTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCACAGCAGC
AACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGC
 129 
TGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGAC
CTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCAGCGCCAG
ATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGAT
TGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCA
TTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCGGAGCCTC
GCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGACCCACCAG
CAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGA
CCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGTGGAGGCG
GTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACT
ACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGTCACCTGAT
GCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACC
GGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGACCACATGGT
GGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCG
GCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTG
AAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACAT
GTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAATCGC
ATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTGATGA
AGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGGAAGA
CGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACG
GTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCCCTGCT
CGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATCGGAAC
AATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGT
CGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCTGAGCG
CCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACATCAACA
ACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCG
GCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCGGATGA
CGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAA
GTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGCAGCA
GCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCACAGTCC
TGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCC
GAGC
 
AAGTGGACCAGGCGGATCAG 
a 1376 bp MscI-HindIII fragment extending from -1755 to -3131 of rosy gene 
(numbering as in Lee et al. 1987,Dutton and Chovnick 1991) is isolated from fly genome 
DNA. This fragment contains all of the putative ORFs identified for the l(3)S12 gene 
(Dutton and Chovnick 1991), as well as 1155bp of additional 3’ sequence. (Quote from 
Horowitz and Berg 1995) 
l(3)S12  
AAGCTTTAAC……CTAGACATGG
AAGCTTTAACTATGTTTAAT (-3131 - -3112) forward primer 
 (-3131- -1755 =>1377bp, but the NCBI sequence 
is 1366bp) 
CTCGTAACCCCTAGACATGG (-1774 - -1755) >>> CCATGTCTAGGGGTTACGAG
AAGCTTTAACTATGTTTAATCTCCCATAGAGCTTCGTTATCTTCGGACGCGAT
GTGGCGCAGATCCCGTGCTTTCGTAACAGTTTTCTCTACGGAATCAGCGGAGG
AATCGGCATCGGCTTGCTGACTTTTCTGGGCACCTCGCGAACCCACCTGTCCA
 
backward primer 
 130 
CCCACGTGGGCTTCGGCTCCTTCTTCTGCGGCACCATCGCCTACTGGATGACC
TGCAGGTAAGTGACTGTGATTAAAACCGTGCGGCGCCCTTATCACTTAATTAT
CAATGTGGCATCCGCAGGTATCAATGGTCCGTCAGGAGATTCGAGCAGCAGC
AATTGCGTGAGGCGATGAGACGACAAGCCCTTTATGAGGGCACCCAAAGGG
AGAGAGACTTAGATCTGAAGTCGGCGTAGCATAAGTCAGATCCTTCATTACT
ACTTCGATGTTTGTTTTCACTCTAGGATACCAAGTAATCCTGGCATTGTTAAA
TCCCTTGTGTTGTAAACTACCTTTTGTTACCAAACTTTATAGTAGCCAATATAT
TATATATATGTTGTAAGTGAAATCTTAGCTTGCCACTCGTAGGGAATTAATTA
TGCCACCATCTTTGATTTGGGATTGACAGAAATCAATCCATCATTTTAATGAT
TGTGGTTCCTAAAACCTGTTGGGCTTTATTGTGCTTTCGATTTGATTTAAGCTG
ATAGAGCTAGTTGTTTACTTTTGAAGAACCTTGAACCCATTTTGACGACCTTT
TAACTTTTTAATAGTTTTTTTTTACCATTTACATAAAAGCAAAATTTACAGTCT
AAAAGTTGTATATTCAATACGTTCTGGTACGTAAAAGGGTTATTTAATGCACC
ATTTTTACAACTTTAGATAGTATACTTTTTACTTGAGTGGGAGCCATATCACA
AAAATGAAATGAAAGGTTAAAAAAGTATCTAAAAGTAAGTTTCAATTAATAT
TCTGAAAAATAATTGCATTTCATGTACGTTTCTCTGAAATACCCCTAATTCGA
TACTATTTATAAATCTGGAAGATATATAGCTAGGAAATAGATTTATATATTTG
CCTAGTTTGAACACCTTGTGAACATTTTGTTTAAAAAAAAAGCGTATCGTGGT
ACTAGAAAACTTTAAGATACAGATAAATAACTTCACTATACCGAGGTTTTGG
TGTTTCTTGAGACTGAAGGACAATCTTCAAAATGGTCTTAATTCTTGAGATAG
AAAAGCTGCAGTTCTCATGCTGAATAGTGATCAGTACGATTTTATCTGACAGA
TTGCTTTCCTAGCTGACCACACCGATCTCGGATGGGTATCTGCTCTAATCCGA
GATAGCAGGTAGTAGAACTGCTGC
 
CTCGTAACCCCTAGACATGG 
TGAGCGCCCA…….
E93 pipsqk  
TTCAGCCGAA 
TGAGCGCCCAGGAGGCATTG (2653-2672) E93 pipsq(F) 
(2653-3097 =>445bp ) 
GCGTTATCCTTTCAGCCGAA (3078-
3097) >>> TTCGGCTGAAAGGATAACGC 
 
E93 pipsq(B)(3097-3078) 
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAG
 
GCGTTATCCTTTCAGCCGAA 
E93 AccI  
ACCCATGTAA……ATCGAAAATC (6569-8284 => 1716 bp)  
ACCCATGTAAAGAAATTGTA  (6569-6588)   E93AccI(F)Forward primer  
TACCGTATGGATCGAAAATC  (8265-8284) >>> GATTTTCGATCCATACGGTA 
E93AccI(B) Backward primer 
 131 
ACCCATGTAAAGAAATTGTAGACAGATCGGATAAAACGAAACTAAACCAAG
CACAAGCTAATGGCCCAAATGCAGTTGGCCCCGAAAATCGAGCGCTGCATTT
GGCCAAGAGAATTTCTTAAGCTACGGCACACATCACTGAAAACAAAAACTGA
AAACTGAATACTGAATACTGAGAATAGGAAACAGTAAGCAGAAGACAAGAT
CGATGGTACTGTTCAGAACATATATAGTTGTATATATTTTGGAATAATGTTTA
CCAGTTCAAGTCAAAATTAAAAGGAAAAAAAAATGCAGTCTTTTATAATGCA
AAATTATACAAAGAAAAATTACAATTTCGCAACGCTAAAAAATGAAAAACG
AAAATATTGATGTAAAAAGAATGAAAATCAAACTTAAAATAATAAACAAGA
TAAAGTGCAATTATACGGTTTAAATAAGCAAATTTAAGAAACAAACGTTATA
AACAAAAACACAAACATGTTAAAACAATGAAAATATTTCGAAGCAAGTTTAG
CTACAAATTCCAAGGCAACTGATAATGACAAGAACCATTTACAAGAAAACCC
AAGACAGCAAAGTACAGTGCGTTTCATAACCCGCAATACGGGCAATCGAATA
CTACCATTCCATTGCCCATGGAGAACTGAAACGCACTTTGGCCCTACTTCATA
TTGATAGGGTAATCGGATCCAAAATCTGTAAACCAAATTTTGGGATCAGCGA
TTAAAACCTTAACGGAAGTTCATAACTGCAGAAAAAAAAAGTCGAAAGTCGA
AATGTCAACCTAGTGGTAGTTCGAAACACAAAAACAAAATAAACCAATCGAG
TGTAATTGAGTGACAGCTTGAGAATGTTGAATTGTATAGAATTTTTGCTTGTG
CACCTGGTCGAGGGGGGCGTGGTTGCGCCCCCTTTTTGGTTTCTAGGTGAACA
GGCGAAAACGCTCAGGTACGTGTTTTATTTTTCGGAGAGAAACAAGATTGAT
TACCCATACATTACTTATTCTTTGTTTTACTACAACATAATAGTTAATATTTGT
ATAAAAAAAAAAGACGACGATGGCGAGAAGGGAAAACCAGCTAAAAAAATT
GATATATTCATAATATAGAATTGTTTTAAATGGTTTGAGAGCGAAAAATATTG
AGGGTTTCTAGCGTGCTTCATGAAATTGCTCATATTTGTGTATAAAACCTTAT
TTGTTCAATGCGAATCAAAATTTGCTGAATATAAGTGCATATATATATAATTA
GAGTTTATTTTTCGGTTTAGTTAAGCGCATAAAATGATTACGATTTAAATAAT
TATTATTAGTTATGACCTAATAGTAGGCAAATCAAAATTTCTTCACATAAAAC
AATCAACTTCTACTTTCAAATAATTTCTAGACGTATGTAACTATAGTTATTATT
CTATTATTATACGGACTAAAACTATTTAGCGCGTTGTTAGACTCGATTTATGG
TTTGTACATATTAGACAACATTTTTATGGTATTCTCCTCTTTTTTTATTATTACT
AGCATTATTACTCCCTATTTTAATTGACTTCTTAAATGGGCAACATCATTTTGA
ACTATAGTGCAATTGTTTCAAACAAAACCAAGCAACCAACAACAAATATATT
AACATTAAAGATTAATATAATTTACAAGCTTTCTTTGCCGATGCCAAGAAGG
ATGAATAACGCATATGTC
 
TACCGTATGGATCGAAAATC 
E93exo5-1(f)(1372-1391): CCACGCCGTCGGGAAGAAGG 
E93 5exoI  
E93exo5-1(b)(1944-1922): Acugcuaaaucugcuguccgcca >>>> 
TGGCGGACAGCAGATTTAGCAGT 
CCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCC
TACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCA
CCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCAT
GACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGAT
GCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGT
TTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAG
CGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCG
GCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGG
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ATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATG
CCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGG
TGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGC
CA 
 
E93exo5-2(f)(2037-2056):Cagcaacatgtcgccgccta 
E93 5exoII  
E93exo5-2(b)(2652-2633):Ccagcaacagcagcaacagc >>>> gctgttgctgctgttgctgg 
CAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACTCCGG
AAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATACTGAA
GATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCG
GGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGCCTCA
GCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGCAGCA
ATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGG
TGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATACAGA
AGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGCCAGG
AGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGCGGCTC
CTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCATTGGC
GGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCAACAGC
ACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC 
 
E93exo5-3(f)(3098-3117):Catgttctggccccagacga 
E93 5exoIII  
E93exo5-3(b)(3899-3880):Tggaccaggcggatcagtta >>> taactgatccgcctggtcca 
CATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAAT
CGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTGA
TGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGGA
AGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGCA
ACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCCC
TGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATCG
GAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAAA
GCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCTG
AGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACATC
AACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGGC
GGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCGG
ATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGCG
AAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGCA
GCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCACA
GTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCAA
GGCCGAGCAAGTGGACCAGGCGGATCAGTTA 
 
CCCTAGAACGCGTTGCTGAA E93_234exo(F)(430-449) 
E93 234exo  
GGCGATGTGAAGTCCGTCAG
 
>>>> CTGACGGACTTCACATCGCC 
E93_234exo(B)(1357-1338) 
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CCCTAGAACGCGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAACATTA
TCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGCCCATA
GCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGCAAG
GAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGTCTG
GAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAGAAC
AACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCAGTA
CACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTGCAA
CTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGG
CCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACATTCA
TCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACATCAGC
AGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCACATT
GCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAACTCCC
TTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGATGGA
CTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGA
TCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATCGCTA
GTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGC
ACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGC
AAACCATCGCCGAACTCATCGATTAGCGGCGATGTGA
 
AGTCCGTCAG 
tatattttaggggaaatccg E93 5exo intron (f) (17829412-17829431)(successful) 
E93 5exo boundary  
GCTGAGGCGGAAGTGGACAG (1578-1597)>>> CTGTCCACTTCCGCCTCAGC 
E93 5exo exon II(b)(1597-1578)  
 
tatattttag gggaaatccg aaacgaattg acagaaatat acaatcttat cacaacacct gagtgagtgg 
TTGTAAAGCA GAATATGACT TTTACGAACT CGCAATAAAC CAATCATCAT  
GAGCTTTAAC AGATATTACG AAATATAACC AGTGTAGGTT TATTATTTAC  
CTATATATAC AGGTATACAT TAGACTTTTA GAAGTTTGTG CTCCTTAAAA  
ACTTTTGGAT TGTCACTATA AACTTAATTT GTTTCCGTTA TCCCTTGCAG  
AGCCTGTGCC ACGCCCACGC CGTCGGGAAG AAGGGCGTAC AGTGAAGAGG  
aTCTGAGCCG GGCCCTACAG GATGTGGTGG CCAACAAGCT AGATGCCCGG  
AAATCGGCTA GCCAGCACCA TGAGCAGCGC TCCATTCTGG ACAACCGGCT  
GTTCAAGATG AAACACCATG ACCAGGAGCA GGATCATGAT GGCGACGAGC 
TCGAGGACTC CAACGATGAT GCTGAGGCGG AAGTGGACAG  
 
Clone_2(f) (1-20) forward primer to make clone_2 unique start: gca gaa ata caa cgc atc 
cg  
clone2-unique start 
Clone_2(b) (592-573) reverse primer to make clone_2 unique start: ctt tcg ggt ttt ttt tta tt 
GCAGAAATACAACGCATCCGATATGCAACGGAACGCATTTTCGGACGCGGCC
CGAGTCGTTCCGAGGTGTAGCGTCCGATTCCGATTCAGATTCAGATTCCGACG
ATCGCGTATATCAATCaTATTAAACAAAAACAACAACTGCAACAACAACGGC
TACACTTTTGTTAGTAAATTTCTGTTGAATTAAAATACGAAACAAAACATATA
AAAAAGTGCAATCCAAAAAAAACAAATATTAACGTTAAACGAACTATAAAG
CAAAATAATTAAAAAAGTAGCCATTACTTTTGAATTGTTTTCAAATGCAAAA
AAGAAAAAGGTTCGTAAGCAACAAAAAAAAAGTTAAATGCTAAAGCATTTT
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GATAATGCAACATATCAAAGAGCCAGAATTTAAACACAGCAAAAAATAAAT
AAAATAATTAATATACAAACACGCGGGGCAACTGTCAAAAAATCTACAACAA
CACAAAGTGCAACTTTCAACAACAACAAAATAAGTGCAGCAGTACAACAAC
AAAAAGCATTACACAATTGAACAAACAACATACAAAAAAAAAATATTGCCA
CCAAATAAAAAAAAACCCGAAAG 
 
TGAGCGCCCAGGAGGCATTG E93 pipsq(F) (2653-2672)  
1st half pipsq (P1) 
Gagcccaagccgcagcccga >>> tcgggctgcggcttgggctC E93 pipsq_II(b)(2878-2859) 
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGA 
 
Tctcgtcggcctgaccggac E93 pipsq_II(f)(2879-2898) 
2nd half pipsq (P2) 
GCGTTATCCTTTCAGCCGAA (3078-
3097) >>> TTCGGCTGAAAGGATAACGC 
TCTCGTCGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAG
GCGGGACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAAC
AATCAGGCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCC
ACGCCCAACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTAT
CCTTTCAGCCGAA 
E93 pipsq(B)(3097-3078) 
 
 
Primers for RTPCR 
 
Primer #1: E93 3rd common exon (E93_3_com_exo(b)) (1357-1338) first strand primer 
for RT-PCR 
GGCGATGTGAAGTCCGTCAG >>>> CTGACGGACTTCACATCGCC 
 
Primer #2: E93 3rd common exon internal (E93_3_com_exo_int(b)) (1323-1304) 
backward PCR primer for RT-PCR 
TAGCAGCAAACCATCGCCGA >>>> TCGGCGATGGTTTGCTGCTA 
 
Primer #3: LP0 unique start primer (LP0_US(f)) (576-596) forward PCR primer or RT-
PCR 
GCCGATTGTTCATATGTGAG 
 
Primer #3: E93 unique start primer (E93_US(f)) (408-428) forward PCR primer for RT-
PCR 
CACATCAGCAGCTATGAAAT 
 
 
 
Clones from cDNA screening 
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AATGAAAAGTCCGCATCAACAATAAAAATCTGCCTGCATTTTTGCCTTTTGTG
TGAGCTGCCCACCAGAACGAGAGAAGCACTTTTATTGTATATAAAAATTATA
TACATCGCCGGGAGGAGCTGCAGCAACCCACTCCAAGCCAGGGTTGCCACGT
CCTGAGCTGCTGTAAGCTCTCCGCAGCAGCTGCAGCAGCATCAGCATCGCAG
CAGCATCAGCAGCAGCGCAGCAACCGCCGCAGCATCAATTTGGCTTTTGGGC
AGAGATAATTTAAGACAAATATATGTGATGCTATGCACATCAGCAGCTATGA
AATATCCCTAGAACGCGTTGCTGAAGAATGTATGGGTCGCAGGCAATGGAAA
CATTATCAAGACAAACTGACGTGCAGCCACTTGAATATCGAGGAGCAACAGC
CCATAGCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAG
CAAGGAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCG
TCTGGAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGA
GAACAACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACC
AGTACACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGT
GCAACTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTT
GGTGGCCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCAC
ATTCATCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACA
TCAGCAGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCC
ACATTGCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAA
CTCCCTTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCG
ATGGACTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCA
ATCTGATCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGAT
CGCTAGTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGT
CCCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTA
GCAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAG
AGCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGA
TCTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAA
TCGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCA
AGATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGG
ACTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGT
GTATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCC
GAGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAA
ATGGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGC
CATCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCT
GGGATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTA
TCAAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCT
AAATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTG
CTGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAG
CAGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGA
CTCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCAT
ACTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTG
TCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACA
GCCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACG
GCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGC
CCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCA
TACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTG
Clone1 (LP library F111 pBluescript SK-) 
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GCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATG
GCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGAT
CATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCC
CAACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGG
CAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAG
CAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTT
GGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGG
CCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTC
CGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAA
CCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAA
GTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACG
TCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAG
GCGGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGC
CACCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACC
AAATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATA
TATATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTG
ACCGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACT
GCATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAAC
AAAAAAAACAAAAA 
 
GCAGAAATACAACGCATCCGATATGCAACGGAACGCATTTTCGGACGCGGCC
CGAGTCGTTCCGAGGTGTAGCGTCCGATTCCGATTCAGATTCAGATTCCGACG
ATCGCGTATATCAATCATATTAAACAAAAACAACAACTGCAACAACAACGGC
TACACTTTTGTTAGTAAATTTCTGTTGAATTAAAATACGAAACAAAACATATA
AAAAAGTGCAATCCAAAAAAAACAAATATTAACGTTAAACGAACTATAAAG
CAAAATAATTAAAAAAGTAGCCATTACTTTTGAATTGTTTTCAAATGCAAAA
AAGAAAAAGGTTCGTAAGCAACAAAAAAAAAGTTAAATGCTAAAGCATTTT
GATAATGCAACATATCAAAGAGCCAGAATTTAAACACAGCAAAAAATAAAT
AAAATAATTAATATACAAACACGCGGGGCAACTGTCAAAAAATCTACAACAA
Clone2 (LP library F211 pBluescript SK-) 
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CACAAAGTGCAACTTTCAACAACAACAAAATAAGTGCAGCAGTACAACAAC
AAAAAGCATTACACAATTGAACAAACAACATACAAAAAAAAAATATTGCCA
CCAAATAAAAAAAAACCCGAAAGAAAATTCGCGCTTCATTTTCACGCGCTGC
ATATAATTTACTCTGTGCTCCACATATATATATATATATATATATAATAAATA
AAAACCAACCAATAGCCCAAAAAAAAAGAAATGAAAAGTCCGCATCAACAA
TAAAAATCTGCCTGCATTTTTGCCTTTTGTGTGAGCTGCCCACCAGAACGAGA
GAAGCACTTTTATTGTATATAAAAATTATATACATCGCCGGGAGGAGCTGCA
GCAACCCACTCCAAGCCAGGGTTGCCACGTCCTGAGCTGCTGTAAGCTCTCC
GCAGCAGCTGCAGCAGCATCAGCATCGCAGCAGCATCAGCAGCAGCGCAGC
AACCGCCGCAGCATCAATTTGGCTTTTGGGCAGAGATAATTTAAGACAAATA
TATGTGATGCTATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCT
GAAGAATGTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGT
GCAGCCACTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGA
GGACGAGCCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAA
TCCCAACCACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGG
CAGCCAGCTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGAT
TCATCACGTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAG
AACCCATCGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCG
CCTGCTAACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACT
GCCACTAGTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACA
GCAACTCGAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAA
CAACAATAGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAG
AGCAACACCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTG
CTGACCCAGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGC
TGGCGCAATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGC
CAACAGCAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACT
ACCTCAGAAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCA
GTCCCAGTGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTC
ATCGATTAGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCG
TCGGGAAGAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGAT
GTGGTGGCCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGC
AGCGCTCCATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGA
GCAGGATCATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCG
GAAGTGGACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGG
CACAACTGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGG
CGAGGATGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGC
AATGCCAGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATG
TCCTGCTGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTG
GATGAAACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACA
GTGGTGGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGA
GAACAGCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAA
CACCATCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCT
ACCGGCATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGA
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
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ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGC
ATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAAC
AGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATAT
CCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAA
TGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAG
AAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGT
TCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTG
ACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAG
GGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTG
GTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCG
GGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAAC
GTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGT
CGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGG
ACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAG
GCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCC
AACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCA
GCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGAC
TTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACG
GCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCAT
CAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGG
CAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACA
CGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAAC
CATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCG
TAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGC
GCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCC
ACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCG
GCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCA
GCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAG
CGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGG
CAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACA
TCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAG
ATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATG
GCCGCGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCT
TCTAGGCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTAC
CATACAAA 
 
TCCGAACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTC
AGCGGTCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTC
ACCACCATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCA
ACCACAGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGC
ATCGCCCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAAC
AGTTTGCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATAT
CCAGCGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAA
TGTTAGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAG
AAGCCGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGT
Clone3 (LP library F311 pBluescript SK-) 
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TCGGAGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTG
ACCCACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAG
GGAACGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTG
GTGGAGGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCG
GGTAGCTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAAC
GTCACCTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGT
CGGCCTGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGG
ACCACATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAG
GCGGCTGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCC
AACGGCCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCA
GCCGAACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGAC
TTCAATCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACG
GCCTGATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCAT
CAGGAAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGG
CAGCAACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACA
CGCCCTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAAC
CATCGGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCG
TAAAGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGC
GCCTGAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCC
ACATCAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCG
GCGGCGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCA
GCCGGATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAG
CGGCGAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGG
CAGCAGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACA
TCACAGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAG
ATCAAGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATG
GCCGCGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCT
TCTAGGCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTAC
CATACAAATCACTAAATAGAATTATATATATATATATATATATATATATACAT
ATATAATAATTTATGCCAGCCAGCTGACCGATGTGCGTGGTAAATGTGCGCT
AGCTCTTAGTTAAATGTGTAATCAACTGCATAGGGGAAAAACAAAACCACAG
GAAATCATAAACAACAACAAACAAACAAAAAAAACAAAAA 
 
CCCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTA
GCAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAG
AGCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGA
TCTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAA
TCGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCA
AGATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGG
ACTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGT
GTATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCC
GAGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAA
ATGGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGC
CATCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCT
GGGATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTA
Clone5 (LP library F511 pBluescript SK-) 
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TCAAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCT
AAATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTG
CTGCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAG
CAGCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGA
CTCCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCAT
ACTGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTG
TCGCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACA
GCCTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACG
GCAGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGC
CCAAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCA
TACAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTG
GCCAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATG
GCGGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGAT
CATTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCC
CAACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGC
TGAGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGT
ATCGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAG
AGGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCC
ACGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGA
GAGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGC
TGCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCA
ATGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAG
CAGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGA
GGCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACG
AACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGC
GGAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACAT
GGTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGA
GGGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGG
GCATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTG
AAGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCA
CCTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGG
CAACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAG
CAGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTT
GGCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGG
CCAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTC
CGAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAA
CCACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAA
GTGCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACG
TCCATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAG
GCGGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGC
CACCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACC
AAATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATA
TATATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTG
ACCGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACT
GCATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAAC
AAAAAAAACAAAA 
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ATAGCAATAGCCGGTTCCGAGGACGAGCCATCGCAATACAACCACAGCAGC
AAGGAGATCAGCCAGAGCAATCCCAACCACTGTAAGACAGAGAACCACCGT
CTGGAGCAGCAACACAACGGCAGCCAGCTATTGGAAGAAGAAGATTCTGAG
AACAACCAAACATCACACGATTCATCACGTACACCAACACCGGGAGCCACCA
GTACACCATCACCACCGCCAGAACCCATCGATTGGAGACCGTCGGCCAAGTG
CAACTTCTGTGTTAACGGTCGCCTGCTAACGGTTAACGCCCAGGGCAAGTTG
GTGGCCGAGTCAGCAGCAACTGCCACTAGTAGTAGCACTAGTAATAGTCACA
TTCATCAGCACGACAGTGACAGCAACTCGAGTGCATCACTGCCCCACCACAT
CAGCAGCAGCAGCAGCAGCAACAACAATAGCAGTGGCAACAGGGCACGCCA
CATTGCTGCTGCAAGTGCAAGAGCAACACCAGCAGCGGCCACACCCGCCAAC
TCCCTTGAACTCTACAAGCTGCTGACCCAGCGGGCAGCCAAAATGACATCGA
TGGACTCGATGGCCGCCCAGCTGGCGCAATTCTCACTGCTGGCCGACTTCAAT
CTGATCAACTCGCTGGCCAGCCAACAGCAGCAGCAGCAGCAGCAACAGATC
GCTAGTGCGGTAACGCCAACTACCTCAGAAGTATCTGCAGCCGCAATCAGTC
CCGCACTCAAAGATACACCCAGTCCCAGTGTGGATGCACCGCTCGATCTTAG
CAGCAAACCATCGCCGAACTCATCGATTAGCGGCGATGTGAAGTCCGTCAGA
GCCTGTGCCACGCCCACGCCGTCGGGAAGAAGGGCGTACAGTGAAGAGGAT
CTGAGCCGGGCCCTACAGGATGTGGTGGCCAACAAGCTAGATGCCCGGAAAT
CGGCTAGCCAGCACCATGAGCAGCGCTCCATTCTGGACAACCGGCTGTTCAA
GATGAAACACCATGACCAGGAGCAGGATCATGATGGCGACGAGCTCGAGGA
CTCCAACGATGATGCTGAGGCGGAAGTGGACAGCAATGCGTCGACACCGGTG
TATCCGGCAGAGTTTGCAAGGGCACAACTGCGCAAACTGAGCCACCTGTCCG
AGCACAATGGCAGCGATCTGGGCGAGGATGTGGATCGTGGATCGCCGAAAAT
GGGGCGACATCCGGCCTGTGGCAATGCCAGTGCCAATCAGGGCGCACCGCCA
TCCATTCCGCTGGATGCCAATGTCCTGCTGCACACTCTGATGCTGGCTGCTGG
GATTGGTGCAATGCCGAAGCTGGATGAAACGCAAACGGTGGGCGACTTTATC
AAGGGTCTGCTGGTGGCCAACAGTGGTGGCATAATGAACGAGGGACTGCTAA
ATCTGCTGTCCGCCAGTCAGGAGAACAGCAATGGCAATGCCTCGCTGCTGCT
GCAACAGCAACAGCATCAGCAACACCATCAGCAACACCATCAGCAGCAGCA
GCAGCAGCAACATGTCGCCGCCTACCGGCATCGCCTGCCCAAGTCGGAGACT
CCGGAAACGAACTCCTCGTTGGATCCGAACGATGCCAGCGAGGATCCCATAC
TGAAGATTCCGTCCTTCAAGGTCAGCGGTCCGGCCAGCAGCAGCAGCCTGTC
GCCGGGCGGACTGGTTGGTGGTCACCACCATCCGCTGAACAACAACAACAGC
CTCAGCATCAGCAACAACAGCAACCACAGCAGCAACAGCCATCGGAACGGC
AGCAATCGCAGCCCGCATTCCGCATCGCCCATGCTGGCCGCGGCCGTGGCCC
AAGGTGGCTACTCCGCCGGCAACAGTTTGCTGACCTCATCCTCGTCTAGCATA
CAGAAGATGATGGCCAGCAATATCCAGCGCCAGATCAACGAACAGAGTGGC
CAGGAGAGTCTCAGGAACGGAAATGTTAGCGATTGCAGCAGCAACAATGGC
GGCTCCTCCTCGCTGGGATACAAGAAGCCGAGCATTTCGGTGGCCAAGATCA
TTGGCGGAACGGACACCTCACGGTTCGGAGCCTCGCCCAATCTGCTGTCCCA
ACAGCACCATTCGGCTCACCACCTGACCCACCAGCAACAGCAGCAACAGCTG
AGCGCCCAGGAGGCATTGGGCAAGGGAACGCGACCAAAGAGGGGCAAGTAT
CGCAACTATGACCGCGACAGTTTGGTGGAGGCGGTCAAGGCGGTGCAGAGA
GGTGAAATGTCGGTTCATCGAGCGGGTAGCTACTACGGCGTACCGCATTCCA
Clone6 (LP library F611 pBluescript SK-) 
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CGCTGGAGTACAAGGTCAAGGAACGTCACCTGATGCGACCGCGCAAGCGAG
AGCCCAAGCCGCAGCCCGATCTCGTCGGCCTGACCGGACCAGCCAACAAGCT
GCAGCTGGACAAACTGAAGGCGGGACCACATGGTGGCTCCAAGCTGAGCAA
TGCCCTCAAGAACCAAAACAATCAGGCGGCTGCGGCGGCGGCGGCGGCAGC
AGCAGCAGCGGCCGCTGCCACGCCCAACGGCCTGAAACTGCCCCTTTTCGAG
GCGGGTCCACAGGCGTTATCCTTTCAGCCGAACATGTTCTGGCCCCAGACGA
ACGCCACGAATGCCTACGGCCTGGACTTCAATCGCATCACGGAGGCGATGCG
GAATCCCCAGGCCTCCAATCACCACGGCCTGATGAAGAGTGCCCAGGACATG
GTGGAGAACGTGTACGATGGCATCATCAGGAAGACGCTGCAGGCGAGCGAG
GGCAATGGCAGTGCGGCGGGTAATGGCAGCAACGGTAGCAATGGCAACGGG
CATGGGCACGGGCATGGCCATGGACACGCCCTGCTCGATCAGCTGCTGGTGA
AGAAGACCCCCTTGCCGTTCACCAACCATCGGAACAATGACTACGCCGCCAC
CTGTTCGAGTGCCAGCGGGGAGAGCGTAAAGCGGTCGGGCAGTCCCATGGGC
AACTATGCAGACATCAAGCGGGAGCGCCTGAGCGCCGACAGCGGCGGCAGC
AGCGATGAGGAGCACTCGGCCAGCCACATCAACAACAACAACAGCGATTTG
GCGCACAACAAGAACAAGAGCGGCGGCGGCGGCGGCGGCGGCGGCAATGGC
CAGACCAATGGGAACGGCAGGAGCAGCCGGATGACGTCGCGGGATGATTCC
GAAACGGATGCCAGCAGCTTGAAGAGCGGCGAAAGTGGCGGCCAGCAAAAC
CACAAAATGATGGATCTCAATGGCGGCAGCAGCAGCAGCAGTCACATCAAGT
GCGAATCGGAGGCGGCCACCGGACATCACAGTCCTGGACACCACACCACGTC
CATACTGCACGAGAAGCTGGCCCAGATCAAGGCCGAGCAAGTGGACCAGGC
GGATCAGTTATAGGAGCAGCCGATGGCCGCGAATCCAGCGTTCGCCTGGCCA
CCGCTGGCCGCCCACTACTACAGCTTCTAGGCGGAGGGAGGGGGAACACCAA
ATTAAGCCACGTTTTTTGATAGTACCATACAAATCACTAAATAGAATTATATA
TATATATATATATATATATATACATATATAATAATTTATGCCAGCCAGCTGAC
CGATGTGCGTGGTAAATGTGCGCTAGCTCTTAGTTAAATGTGTAATCAACTGC
ATAGGGGAAAAACAAAACCACAGGAAATCATAAACAACAACAAACAAACAA
AAAAAACAAAAA 
 
TGCAGCAGCATCAGCATCGCAGCAGCATCAGCAGCAGCGCAGCAACCGCCG
CAGCATCAATTTGGCTTTTGGGCAGAGATAATTTAAGACAAATATATGTGAT
GCTATGCACATCAGCAGCTATGAAATATCCCTAGAACGCGTTGCTGAAGAAT
GTATGGGTCGCAGGCAATGGAAACATTATCAAGACAAACTGACGTGCAGCCA
CTTGAATATCGAGGAGCAACAGCCCATAGCAATAGCCGGTTCCGAGGACGAG
CCATCGCAATACAACCACAGCAGCAAGGAGATCAGCCAGAGCAATCCCAAC
CACTGTAAGACAGAGAACCACCGTCTGGAGCAGCAACACAACGGCAGCCAG
CTATTGGAAGAAGAAGATTCTGAGAACAACCAAACATCACACGATTCATCAC
GTACACCAACACCGGGAGCCACCAGTACACCATCACCACCGCCAGAACCCAT
CGATTGGAGACCGTCGGCCAAGTGCAACTTCTGTGTTAACGGTCGCCTGCTA
ACGGTTAACGCCCAGGGCAAGTTGGTGGCCGAGTCAGCAGCAACTGCCACTA
GTAGTAGCACTAGTAATAGTCACATTCATCAGCACGACAGTGACAGCAACTC
GAGTGCATCACTGCCCCACCACATCAGCAGCAGCAGCAGCAGCAACAACAAT
AGCAGTGGCAACAGGGCACGCCACATTGCTGCTGCAAGTGCAAGAGCAACA
CCAGCAGCGGCCACACCCGCCAACTCCCTTGAACTCTACAAGCTGCTGACCC
AGCGGGCAGCCAAAATGACATCGATGGACTCGATGGCCGCCCAGCTGGCGC
Clone7 (LP library F711 pBluescript SK-) 
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AATTCTCACTGCTGGCCGACTTCAATCTGATCAACTCGCTGGCCAGCCAACAG
CAGCAGCAGCAGCAGCAACAGATCGCTAGTGCGGTAACGCCAACTACCTCAG
AAGTATCTGCAGCCGCAATCAGTCCCGCACTCAAAGATACACCCAGTCCCAG
TGTGGATGCACCGCTCGATCTTAGCAGCAAACCATCGCCGAACTCATCGATT
AGCGGCGATGTGAAGTCCGTCAGAGCCTGTGCCACGCCCACGCCGTCGGGAA
GAAGGGCGTACAGTGAAGAGGATCTGAGCCGGGCCCTACAGGATGTGGTGG
CCAACAAGCTAGATGCCCGGAAATCGGCTAGCCAGCACCATGAGCAGCGCTC
CATTCTGGACAACCGGCTGTTCAAGATGAAACACCATGACCAGGAGCAGGAT
CATGATGGCGACGAGCTCGAGGACTCCAACGATGATGCTGAGGCGGAAGTG
GACAGCAATGCGTCGACACCGGTGTATCCGGCAGAGTTTGCAAGGGCACAAC
TGCGCAAACTGAGCCACCTGTCCGAGCACAATGGCAGCGATCTGGGCGAGGA
TGTGGATCGTGGATCGCCGAAAATGGGGCGACATCCGGCCTGTGGCAATGCC
AGTGCCAATCAGGGCGCACCGCCATCCATTCCGCTGGATGCCAATGTCCTGC
TGCACACTCTGATGCTGGCTGCTGGGATTGGTGCAATGCCGAAGCTGGATGA
AACGCAAACGGTGGGCGACTTTATCAAGGGTCTGCTGGTGGCCAACAGTGGT
GGCATAATGAACGAGGGACTGCTAAATCTGCTGTCCGCCAGTCAGGAGAACA
GCAATGGCAATGCCTCGCTGCTGCTGCAACAGCAACAGCATCAGCAACACCA
TCAGCAACACCATCAGCAGCAGCAGCAGCAGCAACATGTCGCCGCCTACCGG
CATCGCCTGCCCAAGTCGGAGACTCCGGAAACGAACTCCTCGTTGGATCCGA
ACGATGCCAGCGAGGATCCCATACTGAAGATTCCGTCCTTCAAGGTCAGCGG
TCCGGCCAGCAGCAGCAGCCTGTCGCCGGGCGGACTGGTTGGTGGTCACCAC
CATCCGCTGAACAACAACAACAGCCTCAGCATCAGCAACAACAGCAACCAC
AGCAGCAACAGCCATCGGAACGGCAGCAATCGCAGCCCGCATTCCGCATCGC
CCATGCTGGCCGCGGCCGTGGCCCAAGGTGGCTACTCCGCCGGCAACAGTTT
GCTGACCTCATCCTCGTCTAGCATACAGAAGATGATGGCCAGCAATATCCAG
CGCCAGATCAACGAACAGAGTGGCCAGGAGAGTCTCAGGAACGGAAATGTT
AGCGATTGCAGCAGCAACAATGGCGGCTCCTCCTCGCTGGGATACAAGAAGC
CGAGCATTTCGGTGGCCAAGATCATTGGCGGAACGGACACCTCACGGTTCGG
AGCCTCGCCCAATCTGCTGTCCCAACAGCACCATTCGGCTCACCACCTGACCC
ACCAGCAACAGCAGCAACAGCTGAGCGCCCAGGAGGCATTGGGCAAGGGAA
CGCGACCAAAGAGGGGCAAGTATCGCAACTATGACCGCGACAGTTTGGTGGA
GGCGGTCAAGGCGGTGCAGAGAGGTGAAATGTCGGTTCATCGAGCGGGTAG
CTACTACGGCGTACCGCATTCCACGCTGGAGTACAAGGTCAAGGAACGTCAC
CTGATGCGACCGCGCAAGCGAGAGCCCAAGCCGCAGCCCGATCTCGTCGGCC
TGACCGGACCAGCCAACAAGCTGCAGCTGGACAAACTGAAGGCGGGACCAC
ATGGTGGCTCCAAGCTGAGCAATGCCCTCAAGAACCAAAACAATCAGGCGGC
TGCGGCGGCGGCGGCGGCAGCAGCAGCAGCGGCCGCTGCCACGCCCAACGG
CCTGAAACTGCCCCTTTTCGAGGCGGGTCCACAGGCGTTATCCTTTCAGCCGA
ACATGTTCTGGCCCCAGACGAACGCCACGAATGCCTACGGCCTGGACTTCAA
TCGCATCACGGAGGCGATGCGGAATCCCCAGGCCTCCAATCACCACGGCCTG
ATGAAGAGTGCCCAGGACATGGTGGAGAACGTGTACGATGGCATCATCAGG
AAGACGCTGCAGGCGAGCGAGGGCAATGGCAGTGCGGCGGGTAATGGCAGC
AACGGTAGCAATGGCAACGGGCATGGGCACGGGCATGGCCATGGACACGCC
CTGCTCGATCAGCTGCTGGTGAAGAAGACCCCCTTGCCGTTCACCAACCATC
GGAACAATGACTACGCCGCCACCTGTTCGAGTGCCAGCGGGGAGAGCGTAA
AGCGGTCGGGCAGTCCCATGGGCAACTATGCAGACATCAAGCGGGAGCGCCT
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GAGCGCCGACAGCGGCGGCAGCAGCGATGAGGAGCACTCGGCCAGCCACAT
CAACAACAACAACAGCGATTTGGCGCACAACAAGAACAAGAGCGGCGGCGG
CGGCGGCGGCGGCGGCAATGGCCAGACCAATGGGAACGGCAGGAGCAGCCG
GATGACGTCGCGGGATGATTCCGAAACGGATGCCAGCAGCTTGAAGAGCGGC
GAAAGTGGCGGCCAGCAAAACCACAAAATGATGGATCTCAATGGCGGCAGC
AGCAGCAGCAGTCACATCAAGTGCGAATCGGAGGCGGCCACCGGACATCAC
AGTCCTGGACACCACACCACGTCCATACTGCACGAGAAGCTGGCCCAGATCA
AGGCCGAGCAAGTGGACCAGGCGGATCAGTTATAGGAGCAGCCGATGGCCG
CGAATCCAGCGTTCGCCTGGCCACCGCTGGCCGCCCACTACTACAGCTTCTAG
GCGGAGGGAGGGGGAACACCAAATTAAGCCACGTTTTTTGATAGTACCATAC
AAATCACTAAATAGAATTATATATATATATATATATATATATATACATATATA
ATAATTTATGCCAGCCAGCTGACCGATGTGCGTGGTAAATGTGCGCTAGCTCT
TAGTTAAATGTGTAATCAACTGCATAGGGGAAAAACAAAACCACAGGAAATC
ATAAACAACAACAAACAAACAAAAAAAACAAAAA 
 
 
 
Bacterial stocks 
 
Box # 
Slot 
# Exp# Name Date Antibiotics Origin 
8 6E 1 E18set1 clone1.3 pSTBlue1 9/8/2004 Amp, Kan Joanna 
8 7E 1 E47aset clone2.2 pSTBlue1 9/8/2004 Amp, Kan Joanna 
8 8E 1 E18set2 clone4.2 pSTBlue1 9/8/2004 Amp, Kan Joanna 
8 1F 1 E47aset2 clone5.5 pSTBlue1 9/8/2004 Amp, Kan Joanna 
8 2F 1 E31set2 clone6.5 pSTBlue1 9/8/2004 Amp, Kan Joanna 
8 3F 2 
E18set3 clone1.4 pSTBlue1 / E93 
unique start 9/22/2004 Amp, Kan Joanna 
8 4F 2 E47aset3 clone2.2 pSTBlue1 9/22/2004 Amp, Kan Joanna 
8 5F 2 E31set3 clone3.4 pSTBlue1 9/22/2004 Amp, Kan Joanna 
8 6F 2 E18set4 clone4.1 pSTBlue1 9/22/2004 Amp, Kan Joanna 
8 7F 2 E47aset4 clone5.2 pSTBlue1 9/22/2004 Amp, Kan Joanna 
8 8F 5 E31set1 clone7 pSTBlue1 9/29/2004 Amp, Kan Joanna 
8 1G 5 E18cg31353 clone2 pSTBlue1 9/29/2004 Amp, Kan Joanna 
8 2G 5 E47 cg31353 clone4 pSTBlue1 9/29/2004 Amp, Kan Joanna 
8 3G 5 E31 cg31353 clone5 pSTBlue1 9/29/2004 Amp, Kan Joanna 
8 4G 7 E31set4 clone31.4.1 pSTBlue1 10/19/2004 Amp, Kan Joanna 
8 7G   LP08695 pOT2   Cmp Flybase 
8 8G  LP08695 unique F pSTBlue 1/6/2005  DMD 
8 2H   
LP0-UAST in DH5a bacteria 
strain    Amp DMD 
8 3H   
LP0-UAST in XL1Blue bacteria 
strain    Amp DMD 
9 1A 11 E93 2/18-4 pBS 8/6/2005 Amp Eric 
9 2A 11 E93 rp-2 pBS 8/6/2005 Amp Eric 
9 3A 11 E93 2/1 rp5 pBS 8/6/2005 Amp Eric 
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9 4A 11 E93 ORF pBluescript II SK+ 8/7/2005 Amp Eric 
9 5A 11 pUAST E93 8/6/2005 Amp Eric 
Joanna 1A 31 E93 ORF NUS-pSTBlue1 3/4/2006 Amp, Kan Joanna 
Joanna 1B 31 E93 ORF NUSII-pSTBlue1 3/4/2006 Amp, Kan Joanna 
Joanna 1C 37 l(3)S12 pSTBlue1 4/20/2006 Amp, Kan Joanna 
Joanna 1D 37 E93 pipsqk pSTBlue1 4/20/2006 Amp, Kan Joanna 
Joanna 1E 29 E93 AccI 6569-8284 pSTBlue1 2/17/2006 Amp, Kan Joanna 
Joanna 1F 67 E93 5exoII pSTBlue1 7/14/2006 Amp, Kan Joanna 
Joanna 1G 67 E93 5exoIII forward pSTBlue1 7/14/2006 Amp, Kan Joanna 
Joanna 1H 67 E93 234exo pSTBlue1 7/14/2006 Amp, Kan Joanna 
Joanna 2A 67 E93 5exoI pSTBlue1 7/14/2006 Amp, Kan Joanna 
Joanna 2B 81 E93 5exoIII backward pSTBlue1 10/2/2006 Amp, Kan Joanna 
Joanna 2C 85 rp49 pBR322(?) 10/5/2006 Amp, Tet 
Karmella 
Haynes 
Joanna 2D 82 
LP library F111 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 2E 82 
LP library F211 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 2F 82 
LP library F311 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 2G 82 
LP library F511 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 2H 82 
LP library F611 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 3A 82 
LP library F711 pBluescript SK- 
in SOLR bacteria strain 10/6/2006 Amp Joanna 
Joanna 3B 88 E93 5exo boundary pSTBlue1 11/1/2006 Amp, Kan Joanna 
Joanna 3C 122 
clone2-unique start pSTBlue1 
forward 6/7/2007 Amp, Kan Joanna 
Joanna 3D 136 LP0_XhoI-pUAST 6/7/2007 Amp Joanna 
Joanna 3E 143 E93 clone2-pCR8/GW/TOPO 9/1/2007 Spec Joanna 
Joanna 3F 145-42 E93-ORF-pCR8/GW/TOPO 10/18/2007 Spec Joanna 
Joanna 3G 144-34 E93-ORF-e47-pCR8/GW/TOPO 10/23/2007 Spec Joanna 
Joanna 3H 144-86 
E93-ORF-CD1-
pCR8/GW/TOPO 11/11/2007 Spec Joanna 
Joanna 4A 150-6 E93-ORF-pTW 12/9/2007 Amp Joanna 
Joanna 4B 151-10 E93-ORF-e47-pTW 12/9/2007 Amp Joanna 
Joanna 4C 152-7 E93-ORF-CD1-pTW 12/9/2007 Amp Joanna 
Joanna 4D 
144-
131 
E93-ORF-Δpip-
pCR8/GW/TOPO 12/16/2007 Spec Joanna 
Joanna 4E 156-7 E93-ORF-Δpip-pTW 1/1/2008 Amp Joanna 
Joanna 4F 143-71 E93-clone2-pCR8/GW/TOPO 1/1/2008 Spec Joanna 
Joanna 4G 165-7 E93-clone2-pTW 1/3/2008 Amp Joanna 
Joanna 4H 187-8 
E93-no-e47-ORF-
pCR8/GW/TOPO Apr-08 Spec Joanna 
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Joanna 5A 186-24 E93-antigen-I-pET28a #B 5/25/2008 Kan Joanna 
Joanna 5B 186-24 E93-antigen-I-pET28a #C 5/25/2008 Kan Joanna 
Joanna 5C 186-25 E93-antigen-II-pET28a #B 5/25/2008 Kan Joanna 
Joanna 5D 186-25 E93-antigen-II-pET28a #C 5/25/2008 Kan Joanna 
Joanna 5E 186-22 E93-antigen-III-pET28a #A 5/25/2008 Kan Joanna 
Joanna 5F 188-35 E93-no-e47-ORF-pTW 5/28/2008 Amp Joanna 
 
 
The Rabbit and Mouse antisera harvested from each bleeding: 
 
 Rabbit A Rabbit B 
 volume box # volume box # 
pre-immune 4.5ml (900ul*5) Rab 2nd 5.4ml (900ul*6)   Rab 2nd 
0.9ml (100ul*9) Rab small 0.9ml (100ul*9) Rab small 
1st bleeding 2.45ml 
(1.2ml*2+50ul) 
Rab small 3.9ml 
(1.2ml*2+0.5ml+ 
0.4ml+0.2ml+100ul*4) 
Rab small 
2nd bleeding 
(1/16/2009) 
45ml (1ml*45)  Rab 2nd 33ml (1ml*33) Rab 2nd 
1.8ml (100ul*18) Rab small 0.9ml (100ul*9) Rab small 
3rd bleeding 
(2/18/2009) 
44.1ml (900ul*49)  Rab 3rd 39.6ml (900ul*44) Rab 3rd 
0.9ml (100ul*9) Rab small 0.8ml (100ul*8) Rab small 
4th bleeding 
(3/17/2009) 
45ml (900ul*50)  Rab 4th 45ml (900ul*50) Rab 4th 
3.6ml (900ul*4) Rab small 500ul  Rab small 
5th bleeding 
(4/16/2009) 
50ml (1ml*50)  Rab 5th 50ml (1ml*50) Rab 5th 
4ml (1ml*4) Rab small 5ml (1ml*5) Rab small 
6th bleeding 
(5/18/2009) 
50.4ml (900ul*56)  Rab 6th 39.6ml (900ul*44) Rab 6th 
0.9ml (900ul*1) Rab small 0.9ml (900ul*1) Rab small 
 
 
Box: Mou small Mouse 
#1 
Mouse 
#2 
Mouse 
#3 
Mouse 
#4 
Mouse 
#5 
Mouse #6 
pre-immune 200ul 200ul 400ul 400ul 300ul 500ul 
1st bleeding 100ul 120ul 100ul 20ul 20ul 100ul 
2nd bleeding 40ul 200ul 200ul 200ul 400ul 150ul 
3rd bleeding 400ul 400ul 400ul 400ul 300ul + 
10ul*4 
250ul + 
10ul*5 
4th bleeding 300ul 300ul 300ul 200ul 200ul 300ul 
5th bleeding 260ul 220ul 240ul 500ul 240ul 900ul 
6th bleeding 500ul 320ul 320ul 660ul 720ul 720ul 
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The bleeding tests from Rabbit and Mouse antisera: 
 
Bleedings  preim 1st  2nd  3rd  4th  5th  6th  
Rabbit A Exp. 248 - - +     
 Exp. 272   +     
 Exp. 284 - - + weak + weak    
 Exp. 301  + weak      + weak 
Rabbit B Exp. 248 - + -     
 Exp. 272   + weak     
 Exp. 284 - + - -    
 Exp. 301  + strong     + weak 
Mouse 1 Exp. 235  +      
 Exp. 248 - + +     
Mouse 2 Exp. 235  +      
 Exp. 248 -  +     
Mouse 3 Exp. 235  +      
 Exp. 248 - + +     
 Exp. 282 - + + +    
Mouse 4 Exp. 235  +      
 Exp. 248 -  -     
 Exp. 282 - - - -    
Mouse 5 Exp. 235  +      
 Exp. 248 -  +     
 Exp. 282 - + + +    
Mouse 6 Exp. 235  +      
 Exp. 248 -  +     
 Exp. 282 - + + +    
 
Exp. 235: surf western blot 
Exp. 248: 2hr AP midgut tissue staining 
Exp. 272: en-Gal4>UAS-LP0 embryo stripes 
Exp. 282: en-Gal4>UAS-LP0 embryo stripes 
Exp. 284: en-Gal4>UAS-LP0 embryo stripes and WT anterior gut cell 
Exp. 301: en-Gal4>UAS-LP0 embryo stripes 
 
Note: The Rabbit B 1st bleeding generated the strongest immune response in all rabbit 
sera, and I used it for most of my experiments. However, I found the 1st bleeding of 
Rabbit B was mislabeled, and it probably came from Rabbit A. But it was too late to 
change all my notes and labels on the eppendorf tubes. To be consistent, I call Rabbit B 
as the rabbit who produced the strongest immune response, and Rabbit A as the rabbit 
who didn’t respond well. Although the Rabbit got a little bit better in its 6th bleeding, it is 
still weaker than the weakest bleeding from Rabbit B (Rabbit 6th bleeding). 
 
